[{"status": "Terminated", "city": "Wilton", "state": "CT", "country": "United States", "classification": "Class I", "openfda": {}, "product_type": "Drugs", "event_id": "88770", "recalling_firm": "Beiersdorf Inc", "address_1": "45 Danbury Rd", "address_2": "N/A", "postal_code": "06897-4405", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the US", "recall_number": "D-0010-2022", "product_description": "Coppertone Pure & Simple 50 Sunscreen Spray (To Deliver) Zinc Oxide 24.08%, NET WT 5 OZ (142 g) can, Beiersdorf Inc., Wilton, CT 06897  UPC 0 72140 02880 0", "product_quantity": "38,328 cans", "reason_for_recall": "Chemical contamination; presence of benzene", "recall_initiation_date": "20210930", "center_classification_date": "20211015", "termination_date": "20230413", "report_date": "20211027", "code_info": "Lot# TN00CJ4, exp. date 06/30/2023"}, {"country": "United States", "city": "Richland", "address_1": "199 Interstate Dr Ste N", "reason_for_recall": "CGMP Deviations; deficiencies at the manufacturer  may result in assay or content uniformity failures", "address_2": "", "product_quantity": "795 bottles", "code_info": "LOT # 29401501, EXP 10/17", "center_classification_date": "20161129", "distribution_pattern": "Nationwide", "state": "MS", "product_description": "Indiomin MB URINARY ANTISEPTIC, ANTISPASMODIC Capsules, Each capsule contains:  Methenamine 120 mg, Monobasic Sodium Phosphate 40.8 mg, Methylene Blue, 10 mg; Hyoscyamine Sulfate, 0.12 mg, 100 count, Rx only, Manufactured for: BUREL PHARMACEUTICALS, NDC 35573-315-10", "report_date": "20161207", "classification": "Class II", "openfda": {}, "recalling_firm": "Burel Pharmaceuticals Inc", "recall_number": "D-0160-2017", "initial_firm_notification": "E-Mail", "product_type": "Drugs", "event_id": "75566", "termination_date": "20170814", "more_code_info": "", "recall_initiation_date": "20161024", "postal_code": "39218-9433", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Terminated", "city": "Hawthorne", "state": "NY", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA209204"], "brand_name": ["IBUPROFEN"], "generic_name": ["IBUPROFEN"], "manufacturer_name": ["Sun Pharmaceutical Industries, Inc."], "product_ndc": ["51672-1385"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["IBUPROFEN"], "rxcui": ["197803"], "spl_id": ["39628a1c-56a6-3f83-e063-6394a90a8c98"], "spl_set_id": ["a8b46ae5-67bc-494d-850e-b4e4ed5a33b3"], "package_ndc": ["51672-1385-8", "51672-1385-9"], "is_original_packager": [true], "nui": ["N0000000160", "M0001335", "N0000175722"], "pharm_class_moa": ["Cyclooxygenase Inhibitors [MoA]"], "pharm_class_cs": ["Anti-Inflammatory Agents, Non-Steroidal [CS]"], "pharm_class_epc": ["Nonsteroidal Anti-inflammatory Drug [EPC]"], "unii": ["WK2XYI10QM"]}, "product_type": "Drugs", "event_id": "83887", "recalling_firm": "Taro Pharmaceuticals U.S.A., Inc.", "address_1": "3 Skyline Dr", "address_2": "", "postal_code": "10532-2174", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "U.S.A. Nationwide", "recall_number": "D-0298-2020", "product_description": "Ibuprofen Oral Suspension USP, 100 mg/5 mL, 4 fl. oz., (118 mL), Rx only, Manufactured by: Taro Pharmaceuticals, Inc., Brampton, Ontario, Canada L6T 1C1, Distributed by: Taro Pharmaceuticals U.S.A., Inc., Hawthorne, NY 10532, NDC 51672-1385-8", "product_quantity": "138,886 bottles", "reason_for_recall": "Presence of Foreign Substance: Ibuprofen Oral Suspension USP may have small particles of an inert plastic material introduced during manufacturing.", "recall_initiation_date": "20190927", "center_classification_date": "20191105", "termination_date": "20230831", "report_date": "20191106", "code_info": "Lot #: K779030125, Exp 10/19; D873031376, Exp 3/20; J871233188, Exp 9/20; L866934047, Exp 11/20; A973134376, 12/20; D967635229, Exp 3/21", "more_code_info": ""}, {"status": "Terminated", "city": "Bannockburn", "state": "IL", "country": "United States", "classification": "Class III", "openfda": {"application_number": ["NDA020451"], "brand_name": ["PHOTOFRIN"], "generic_name": ["PORFIMER SODIUM"], "manufacturer_name": ["Pinnacle Biologics, Inc."], "product_ndc": ["76128-155"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["INTRAVENOUS"], "substance_name": ["PORFIMER SODIUM"], "rxcui": ["242166", "687066"], "spl_id": ["3f74d94c-ce73-4f3f-abc6-050a8d86dac4"], "spl_set_id": ["5c4841b4-fbc0-4163-8ee1-cb28629cbfbf"], "package_ndc": ["76128-155-75"], "is_original_packager": [true], "upc": ["0376128155756"], "unii": ["Y3834SIK5F"]}, "product_type": "Drugs", "event_id": "67688", "recalling_firm": "Pinnacle Biologics Inc", "address_1": "2801 Lakeside Dr Ste 209", "address_2": "N/A", "postal_code": "60015-1271", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "US: Nationwide and Taiwan", "recall_number": "D-1157-2014", "product_description": "Photofrin (porfimer sodium) for Injection, 75 mg Single Use Flip-Top Vial, Rx Only. Manufactured for: Pinnacle Biologics, Inc. Bannockburn, IL 60015. NDC:76128-155-75", "product_quantity": "261 vials", "reason_for_recall": "Stability Data Does Not Support Expiry: Printed expiration date should be Nov 2013 rather than Nov 2014.", "recall_initiation_date": "20140210", "center_classification_date": "20140312", "termination_date": "20150522", "report_date": "20140319", "code_info": "Lot Number: 0M396; Expiry: Nov 2014"}, {"status": "Terminated", "city": "Pulaski", "state": "TN", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA078720"], "brand_name": ["AMANTADINE HCL"], "generic_name": ["AMANTADINE HYDROCHLORIDE"], "manufacturer_name": ["AvPAK"], "product_ndc": ["50268-069"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["AMANTADINE HYDROCHLORIDE"], "rxcui": ["849389"], "spl_id": ["38566e1f-b7b1-540f-e063-6394a90a2760"], "spl_set_id": ["461e6444-189e-62ed-6c61-1c36a04459c6"], "package_ndc": ["50268-069-11", "50268-069-15"], "original_packager_product_ndc": ["69452-142"], "unii": ["M6Q1EO9TD0"]}, "product_type": "Drugs", "event_id": "79680", "recalling_firm": "AVKARE Inc.", "address_1": "615 N 1st St", "address_2": "", "postal_code": "38478-2403", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide", "recall_number": "D-0633-2018", "product_description": "Amantadine HCl Capsules, USP, 100 mg, 50 Capsules (5x10) Unite Dose, Rx Only, Manufactured for: AvKARE Inc. Pulaski, TN 38478 --- NDC 50268-069-15", "product_quantity": "2135 cartons", "reason_for_recall": "Failed Dissolution Specifications", "recall_initiation_date": "20180330", "center_classification_date": "20180417", "termination_date": "20200604", "report_date": "20180425", "code_info": "Lot: 16719 Exp. 07/2018", "more_code_info": ""}, {"status": "Ongoing", "city": "East Windsor", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA202519"], "brand_name": ["VALSARTAN AND HYDROCHLOROTHIAZIDE"], "generic_name": ["VALSARTAN AND HYDROCHLOROTHIAZIDE"], "manufacturer_name": ["Aurobindo Pharma Limited"], "product_ndc": ["65862-547", "65862-548", "65862-549", "65862-550", "65862-551"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["HYDROCHLOROTHIAZIDE", "VALSARTAN"], "rxcui": ["200284", "200285", "349353", "636042", "636045"], "spl_id": ["81a03db7-4be2-478d-b625-e59c8bd2235f"], "spl_set_id": ["c5bc7c55-b50c-4e61-ad1f-5ebb607c262f"], "package_ndc": ["65862-547-90", "65862-547-99", "65862-547-10", "65862-548-90", "65862-548-99", "65862-548-10", "65862-549-90", "65862-549-99", "65862-549-10", "65862-550-90", "65862-550-05", "65862-551-90", "65862-551-05"], "is_original_packager": [true], "nui": ["N0000175359", "N0000175419", "M0471776", "N0000000070", "N0000175561"], "pharm_class_pe": ["Increased Diuresis [PE]"], "pharm_class_epc": ["Thiazide Diuretic [EPC]", "Angiotensin 2 Receptor Blocker [EPC]"], "pharm_class_cs": ["Thiazides [CS]"], "pharm_class_moa": ["Angiotensin 2 Receptor Antagonists [MoA]"], "unii": ["0J48LPH2TH", "80M03YXJ7I"]}, "product_type": "Drugs", "event_id": "81887", "recalling_firm": "Aurobindo Pharma USA Inc.", "address_1": "279 Princeton Hightstown Rd", "address_2": "", "postal_code": "08520-1401", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "Product was distributed to 25 distributors and Retail Chains who may have further distributed the product throughout the United States.", "recall_number": "D-0366-2019", "product_description": "Valsartan and Hydrochlorothiazide tablets USP 160mg/12.5 mg, 90-count bottle, Rx Only, Manufactured for: Aurobindo Pharma USA, Inc., Dayton, NJ 08810. NDC 65862-548-90.", "product_quantity": "92,616 bottles", "reason_for_recall": "CGMP Deviations: FDA lab confirmed presence an impurity, N-nitrosodimethylamine (NDEA) contained in the API used to manufacture the product above the interim acceptable daily intake level of 0.083 parts per million.", "recall_initiation_date": "20181231", "center_classification_date": "20190114", "report_date": "20190123", "code_info": "Lot # HTSA17033-A, exp. date 10/2020  Lot # HTSA17034-A, exp. date 10/2020  Lot # HTSA17035-A, exp. date 10/2020  Lot # HTSA17036-A, exp. date 10/2020  Lot # HTSA17040-A, exp. date 10/2020  Lot # HTSA17041-A, exp. date 11/2020  Lot # HTSA17042-A, exp. date 11/2020  Lot # HTSA17043-A, exp. date 11/2020  Lot # HTSA17037-A, exp. date 10/2020  Lot # HTSA17039-A, exp. date 10/2020", "more_code_info": ""}, {"country": "United States", "city": "Vancouver", "address_1": "14301 Se 1st St", "reason_for_recall": "Labeling:Label Mixup; OLANZapine, Tablet, 7.5 mg may be potentially mislabeled as    LEVOTHYROXINE SODIUM, Tablet, 175 mcg, NDC 00527135001, Pedigree: AD46265_37, EXP: 5/15/2014;  LEVOTHYROXINE SODIUM, Tablet, 88 mcg, NDC 00781518392, Pedigree: AD60272_73, EXP: 5/22/2014;  MIRTAZAPINE, Tablet, 7.5 mg, NDC 59762141503, Pedigree: AD73525_55, EXP: 5/30/2014.", "address_2": "", "product_quantity": "210 Tablets", "code_info": "OLANZapine, Tablet, 7.5 mg has the following codes    Pedigree: AD46265_46, EXP: 5/15/2014;  Pedigree: AD60272_79, EXP: 5/22/2014;  Pedigree: AD73525_58, EXP: 5/30/2014.", "center_classification_date": "20140116", "distribution_pattern": "Repacked drugs were distributed in Arizona, California, Oregon, and Washington.", "state": "WA", "product_description": "OLANZapine Tablet, 7.5 mg, Rx only, Distributed by: AidaPak Service, LLC, NDC 55111016530", "report_date": "20140122", "classification": "Class II", "openfda": {}, "recalling_firm": "Aidapak Services, LLC", "recall_number": "D-619-2014", "initial_firm_notification": "Telephone", "product_type": "Drugs", "event_id": "65707", "termination_date": "20140207", "more_code_info": "", "recall_initiation_date": "20130702", "postal_code": "98684-3501", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Terminated", "city": "North Wales", "state": "PA", "country": "United States", "classification": "Class III", "openfda": {"application_number": ["ANDA208784"], "brand_name": ["LANSOPRAZOLE"], "generic_name": ["LANSOPRAZOLE"], "manufacturer_name": ["Teva Pharmaceuticals USA, Inc."], "product_ndc": ["0093-3008", "0093-3009"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["LANSOPRAZOLE"], "rxcui": ["351260", "351261"], "spl_id": ["eaa2693b-b9df-4cf3-b212-5de87110aa89"], "spl_set_id": ["6b8dd0e1-cd69-4f9a-887f-e42627b5d78e"], "package_ndc": ["0093-3008-19", "0093-3008-93", "0093-3009-19", "0093-3009-93"], "is_original_packager": [true], "nui": ["N0000175525", "N0000000147", "N0000009724"], "pharm_class_epc": ["Proton Pump Inhibitor [EPC]"], "pharm_class_moa": ["Proton Pump Inhibitors [MoA]"], "pharm_class_pe": ["Inhibition Gastric Acid Secretion [PE]"], "unii": ["0K5C5T2QPG"]}, "product_type": "Drugs", "event_id": "82367", "recalling_firm": "Teva Pharmaceuticals USA", "address_1": "1090 Horsham Rd", "address_2": "N/A", "postal_code": "19454-1505", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the United States.", "recall_number": "D-1006-2019", "product_description": "Lansoprazole Delayed-Release Orally Disintegrating Tablets, 15 mg, 100 tablets (10 blister cards of 10 tablets each), Rx only, Manufactured in Israel By: Teva Pharmaceutical Ind. Ltd. Jerusalem, 9777402,  Israel, Manufactured for: Teva Pharmaceuticals USA, Inc. North Wales, PA 19454, NDC 0093-3008-93", "product_quantity": "7,081 bottles", "reason_for_recall": "Subpotent Drug.", "recall_initiation_date": "20190311", "center_classification_date": "20190315", "termination_date": "20191115", "report_date": "20190327", "code_info": "Lot #: 25Q002, Exp. 11/2019"}, {"country": "United States", "city": "New York", "address_1": "767 5th Ave Fl 47th", "reason_for_recall": "Stability Data Does Not Support Expiry", "address_2": "", "product_quantity": "3,791 tubes", "code_info": "All lot codes and shipment dates are being recalled. 2.6oz/75ml. in a light green carton, UPC: 8-82381-07901-7 Code: D079-01-1000", "center_classification_date": "20140724", "distribution_pattern": "Nationwide", "state": "NY", "product_description": "DENBLAN Anticavity Fluoride Toothpaste, Whitening formula, sodium monofluorophosphate 0.76%, 2.6 oz/75 mL tube, Laboratories Darphin, Dist, Paris France", "report_date": "20140730", "classification": "Class III", "openfda": {}, "recalling_firm": "Estee Lauder Inc", "recall_number": "D-1452-2014", "initial_firm_notification": "E-Mail", "product_type": "Drugs", "event_id": "68449", "termination_date": "20151119", "more_code_info": "", "recall_initiation_date": "20140606", "postal_code": "10153-0023", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Terminated", "city": "Lake Forest", "state": "IL", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "82177", "recalling_firm": "Akorn Inc", "address_1": "1925 W Field Ct Ste 300", "address_2": "", "postal_code": "60045-4862", "voluntary_mandated": "", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA.", "recall_number": "D-0511-2019", "product_description": "Moisturizing Lubricant Eye Drops, 0.25% Sodium Carboxymethylcellulose, 0.5 Fl OZ (15mL) Distributed by: Walgreen Co, 200 Wilmont Rd Deerfield IL 60015 NDC 00363-9651-01.", "product_quantity": "78120 dropper bottles", "reason_for_recall": "Failed Stability Specification: out of specification results for Sodium Perborate", "recall_initiation_date": "20190204", "center_classification_date": "20190219", "termination_date": "20220729", "report_date": "20190227", "code_info": "Lot # 8D31A, Exp: 03/20;  7H98A, Exp: 07/19; 7L80A, Exp: 10/19.", "more_code_info": ""}, {"country": "United States", "city": "Doral", "address_1": "5771 NW 112th Ave Apt 112", "reason_for_recall": "Marketed Without An Approved NDA/ANDA: Dietary supplements contains undeclared sibutramine, desmethylsibutramine and phenolphthalein based on FDA sampling.", "address_2": "", "product_quantity": "783 bottles", "code_info": "Lot # 000815004400; Exp 12/17", "center_classification_date": "20160212", "distribution_pattern": "Nationwide and Colombia, South America", "state": "FL", "product_description": "Akttive High Performance Fat Burner Gold dietary supplement capsules, 30-count bottle, Distributed by Life and More, L.L.C., Doral, Florida", "report_date": "20160224", "classification": "Class I", "openfda": {}, "recalling_firm": "Life and More LLC", "recall_number": "D-0664-2016", "initial_firm_notification": "E-Mail", "product_type": "Drugs", "event_id": "71733", "more_code_info": "", "recall_initiation_date": "20150713", "postal_code": "33178-4161", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Ongoing"}, {"status": "Terminated", "city": "Boca Raton", "state": "FL", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "83789", "recalling_firm": "KRS Global Biotechnology, Inc", "address_1": "791 Park of Commerce Blvd Ste 600", "address_2": "N/A", "postal_code": "33487-3633", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "Nationwide", "recall_number": "D-0110-2020", "product_description": "Vitamin 10 B Lyophilized, Vial, For IM Use,  Rx Only, KRS Global Biotechnology 791 Park of Commerce Blvd, Boca Raton, FL 33487. NDC3321678338", "product_quantity": "6747 vials", "reason_for_recall": "Lack of Assurance of Sterility", "recall_initiation_date": "20190912", "center_classification_date": "20191001", "termination_date": "20210819", "report_date": "20191009", "code_info": "All lots remaining within expiry."}, {"status": "Terminated", "city": "Livonia", "state": "MI", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "88811", "recalling_firm": "The Harvard Drug Group", "address_1": "17187 N Laurel Park Dr Ste 300", "address_2": "N/A", "postal_code": "48152-2600", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide USA", "recall_number": "D-0289-2022", "product_description": "Fexofenadine Hydrochloride Tablets, 60 mg, 500 Tablets per bottle, Distributed by: Major Pharmaceuticals, 17177 N. Laurel Park Drive, Suite 233, Livonia, MI 48152  NDC 0904-6979-40", "product_quantity": "2,239 bottles", "reason_for_recall": "Failed Impurities/Degradation Specifications", "recall_initiation_date": "20210803", "center_classification_date": "20211221", "termination_date": "20230716", "report_date": "20211229", "code_info": "Lot, expiry: Lot H00005, exp 01/2022; Lot H00006, exp 04/2022; Lot H00007, exp 07/2022"}, {"status": "Ongoing", "city": "Gurnee", "state": "IL", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "91788", "recalling_firm": "Akorn, Inc.", "address_1": "5605 Centerpoint Ct Ste A", "address_2": "N/A", "postal_code": "60031-5278", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA and Puerto Rico", "recall_number": "D-0840-2023", "product_description": "Rifampin Capsules USP, 150 mg, 30-count bottles, Rx Only, Sterile, Distributed by: Akorn Operating Company LLC, Gurnee, IL 60031. ALL NDCs", "product_quantity": "N/A", "reason_for_recall": "CGMP Deviations: Firm went out of business and could no longer continue stability studies.", "recall_initiation_date": "20230426", "center_classification_date": "20230601", "report_date": "20230607", "code_info": "All Lots"}, {"status": "Terminated", "city": "Monterey Park", "state": "CA", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "83437", "recalling_firm": "Herbal Doctor Remedies", "address_1": "497 Cumbre St", "address_2": "N/A", "postal_code": "91754-2114", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "N/A", "distribution_pattern": "Nationwide within the United States and Brazil and on the internet", "recall_number": "D-1592-2019", "product_description": "Cardia Forte, 500 mg Capsules, 90-count bottles, Herbal Doctor Remedies Alhambra, CA 91801-7081 USA, 1(800) 600-0808", "product_quantity": "N/A", "reason_for_recall": "CGMP Deviations: Products were manufactured outside of the controls required by current Good Manufacturing Practices.", "recall_initiation_date": "20190712", "center_classification_date": "20190802", "termination_date": "20230613", "report_date": "20190814", "code_info": "All lots within expiry"}, {"status": "Terminated", "city": "Saint Louis", "state": "MO", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "72479", "recalling_firm": "Steris Corp", "address_1": "7501 Page Ave", "address_2": "N/A", "postal_code": "63133-1031", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Medical Center/Hospitals in FL, MO, and TN.", "recall_number": "D-0518-2016", "product_description": "Kindest Kare Antimicrobial Foaming Handwash, Hand Soap, 0.75% Triclosan, 444 ml (15 fl oz) bottles, STERIS Corporation, 7501 Page Avenue, St. Louis, MO  63133, Reorder # 1452-RF, NDC 0519-1452-13, UPC (01)00724995 086251.", "product_quantity": "3 cases - 54 bottles", "reason_for_recall": "Labeling: Not Elsewhere Classified; Incorrect/Undeclared Excipients: Outdated previous version of label applied to products that incorrectly states one inactive ingredient.", "recall_initiation_date": "20151027", "center_classification_date": "20151204", "termination_date": "20160707", "report_date": "20151216", "code_info": "Lot # 277120, Exp 06/01/17", "more_code_info": ""}, {"status": "Terminated", "city": "Las Vegas", "state": "NV", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "74187", "recalling_firm": "Well Care Compounding Pharmacy", "address_1": "3430 E Tropicana Ave Ste 9", "address_2": "N/A", "postal_code": "89121-7345", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "NV", "recall_number": "D-1004-2016", "product_description": "PHENYLEPHERINE 0.5%, packaged in 5mL vials, Rx only, Well Care Compounding Pharmacy Las Vegas, NV 89121", "product_quantity": "869 Units (Total All Products)", "reason_for_recall": "Lack of Assurance of Sterility: FDA inspection identified GMP violations potentially impacting product quality and sterility.", "recall_initiation_date": "20160517", "center_classification_date": "20160609", "termination_date": "20170113", "report_date": "20160615", "code_info": "Lot #: 01282016:60@3, Exp.04/28/2016; Lot #: 02242016:  90@20, Exp.05/24/2016; Lot #: 02222016:06@67, Exp.  05/24/2016; Lot #: 03082016:81@21, Exp.06/06/2016; Lot #: 03162016:  62@1, Exp. 06/14/2016."}, {"status": "Terminated", "city": "Lake Forest", "state": "IL", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "75418", "recalling_firm": "Akorn Inc", "address_1": "1925 W Field Ct", "address_2": "", "postal_code": "60045-4862", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide and Puerto Rico", "recall_number": "D-0124-2017", "product_description": "Sodium Chloride Ophthalmic Solution, USP, 5%, 15 mL (0.5 fL oz.) bottle, Akorn, Inc., Lake Forest, IL 60045, NDC 17478-623-12.", "product_quantity": "29,972 bottles", "reason_for_recall": "Subpotent Drug: concentration of product is less than labeled amount.", "recall_initiation_date": "20161021", "center_classification_date": "20161102", "termination_date": "20190510", "report_date": "20161109", "code_info": "Lot: 041306A, Exp 04/19", "more_code_info": ""}, {"status": "Terminated", "city": "Newark", "state": "CA", "country": "United States", "classification": "Class I", "openfda": {}, "product_type": "Drugs", "event_id": "78151", "recalling_firm": "Gadget Island, Inc", "address_1": "5889 Central Ave", "address_2": "N/A", "postal_code": "94560-4465", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "E-Mail", "distribution_pattern": "Nationwide in the USA", "recall_number": "D-0105-2018", "product_description": "FIFTY SHADES 6000 capsule, Proprietary Raw Material 4550, 1-capsule packets, distributed by Express Pac Trading, UPC 4026666146056", "product_quantity": "273 1-capsule packets", "reason_for_recall": "Marketed without an Approved NDA/ANDA: undeclared Active Pharmaceutical Ingredients sildenafil, desmethyl carbodenafil and tadalafil.", "recall_initiation_date": "20170915", "center_classification_date": "20171204", "termination_date": "20181204", "report_date": "20171213", "code_info": "All Lots", "more_code_info": ""}, {"status": "Terminated", "city": "Colchester", "state": "VT", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "89172", "recalling_firm": "Edge Pharma, LLC", "address_1": "856 Hercules Dr", "address_2": "", "postal_code": "05446-8014", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "nationwide", "recall_number": "D-0407-2022", "product_description": "Mitomycin-C, 40mg/40mL (1mg/mL), 40 mL per syringe, Single Dose Syringe for Intravesical Use, Edge Pharma, LLC, 856 Hercules Dr., Colchester, VT 05446, NDC 05446-1416-01", "product_quantity": "860 syringes", "reason_for_recall": "Lack of Assurance of Sterility", "recall_initiation_date": "20211206", "center_classification_date": "20220124", "termination_date": "20230607", "report_date": "20220202", "code_info": "08-2021-24@5 12/09/2021,  08-2021-27@2 12/21/2021,  08-2021-31@5 12/14/2021, 09-2021-02@2 12/15/2021, 09-2021-09@2 12/22/2021, 09-2021-15@3 12/29/2021, 09-2021-22@2 01/04/2022 & 10-2021-26@5 02/07/2022", "more_code_info": ""}, {"status": "Ongoing", "city": "Irvine", "state": "CA", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["NDA016733"], "brand_name": ["SODIUM CHLORIDE"], "generic_name": ["SODIUM CHLORIDE"], "manufacturer_name": ["B. Braun Medical Inc."], "product_ndc": ["0264-2201"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["IRRIGATION"], "substance_name": ["SODIUM CHLORIDE"], "rxcui": ["486515"], "spl_id": ["35e26a6d-60d6-4388-84e9-c481a3b69ee7"], "spl_set_id": ["0d59a04a-32e6-485b-b638-a1e6c09e9642"], "package_ndc": ["0264-2201-00", "0264-2201-10", "0264-2201-50", "0264-2201-70"], "is_original_packager": [true], "unii": ["451W47IQ8X"]}, "product_type": "Drugs", "event_id": "96605", "recalling_firm": "B. Braun Medical Inc", "address_1": "2525 Mcgaw Ave", "address_2": "N/A", "postal_code": "92614-5841", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Product was distributed to 12 distributors who may have further distributed the product nationwide.", "recall_number": "D-0353-2025", "product_description": "0.9% Sodium chloride Irrigation USP, Isotonic Solution for Irrigation, 500 mL Plastic Irrigation Container (PIC), B. Braun Medical, Inc., Bethlehem, PA 18018-3524 USA, NDC 0264-2201-10", "product_quantity": "32,256 Bottles", "reason_for_recall": "Presence of Particulate Matter", "recall_initiation_date": "20250331", "center_classification_date": "20250408", "report_date": "20250416", "code_info": "Lot # J4K936, Exp 7/31/2027"}, {"status": "Terminated", "city": "Mesa", "state": "AZ", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "88693", "recalling_firm": "First Royal Care Co. LLC, dba Red Mountain Compounding Pharmacy", "address_1": "6828 E Brown Rd Ste 101", "address_2": "N/A", "postal_code": "85207-3761", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "N/A", "distribution_pattern": "494 patients/consumers received prescriptions and are located in AZ, CA FL, MN, MT, TX, and UT.", "recall_number": "D-0047-2022", "product_description": "TEST CYP/PROP 160/40MG/ML MDV IN ETHYL OLEATE, Rx only, Red Mountain Compounding Rx", "product_quantity": "N/A", "reason_for_recall": "Lack of Assurance of Sterility: FDA inspection raised sterility assurance concerns", "recall_initiation_date": "20210813", "center_classification_date": "20211026", "termination_date": "20230412", "report_date": "20211103", "code_info": "all lots within expiry"}, {"country": "United States", "city": "Bridgewater", "address_1": "55 Corporate Dr", "reason_for_recall": "CGMP Deviations: Presence of NDMA impurity detected in product.", "address_2": "", "product_quantity": "", "code_info": "all lots", "center_classification_date": "20191201", "distribution_pattern": "Nationwide", "state": "NJ", "product_description": "Regular Strength Zantac 75 mg, Distributed by: Chattem, Inc., a Sanofi Company P.O. Box 2219, Chattanooga, TN 37409-0219. NDC 68151-2584-0.", "report_date": "20191211", "classification": "Class II", "openfda": {}, "recalling_firm": "Sanofi-Aventis U.S. LLC", "recall_number": "D-0543-2020", "initial_firm_notification": "Letter", "product_type": "Drugs", "event_id": "84122", "more_code_info": "", "recall_initiation_date": "20191022", "postal_code": "08807-1265", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Ongoing"}, {"status": "Terminated", "city": "Richmond", "state": "VA", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["NDA019430"], "brand_name": ["EPIPEN"], "generic_name": ["EPINEPHRINE"], "manufacturer_name": ["Viatris Specialty LLC"], "product_ndc": ["49502-500", "49502-501"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["INTRAMUSCULAR"], "substance_name": ["EPINEPHRINE"], "rxcui": ["727316", "727347", "727386", "1870207"], "spl_id": ["81569d26-e9b3-4c1d-ac34-8a4cf5b4a98b"], "spl_set_id": ["7560c201-9246-487c-a13b-6295db04274a"], "package_ndc": ["49502-500-01", "49502-500-02", "49502-500-92", "49502-501-01", "49502-501-02", "49502-501-92"], "is_original_packager": [true], "nui": ["N0000000209", "N0000000245", "N0000175552", "N0000175555", "N0000175570", "M0003647"], "pharm_class_moa": ["Adrenergic alpha-Agonists [MoA]", "Adrenergic beta-Agonists [MoA]"], "pharm_class_epc": ["alpha-Adrenergic Agonist [EPC]", "beta-Adrenergic Agonist [EPC]", "Catecholamine [EPC]"], "pharm_class_cs": ["Catecholamines [CS]"], "unii": ["YKH834O4BH"]}, "product_type": "Drugs", "event_id": "89646", "recalling_firm": "Mckesson Medical-Surgical Inc. Corporate Office", "address_1": "9954 Maryland Drive", "address_2": "Deep Run Iii Ste. 4000", "postal_code": "23233", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "USA nationwide.", "recall_number": "D-0993-2022", "product_description": "EPI-PEN 2-PAK (epinephrine injection, USP), Single-Dose Auto-Injectors 0.3 mg, Rx only, Manufactured for: Mylan Specialty LP., NDC 49502-500-02", "product_quantity": "5 cartons", "reason_for_recall": "cGMP deviations: Temperature abuse", "recall_initiation_date": "20220413", "center_classification_date": "20220609", "termination_date": "20231130", "report_date": "20220615", "code_info": "McKesson Medical-Surgical (MMS) is not able to identify the particular lot number received by a particular consignee for the recalled prescription products. Each letter includes the date it was distributed to customers and the dates that impacted product may have been shipped to the customer.     The letters clearly explain that consignees should identify product received from MMS between June 1 and September 30, 2021. A consignee should be able to use its own records to determine whether it received an impacted product from MMS during that timeframe and whether it still has any of that product in inventory. The recall notification letter informs consignees that they may contact Sedgwick if they have any questions.", "more_code_info": ""}, {"status": "Ongoing", "city": "Skillman", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "88288", "recalling_firm": "Johnson & Johnson Consumer, Inc.", "address_1": "199 Grandview Rd", "address_2": "N/A", "postal_code": "08558-1311", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit", "distribution_pattern": "Nationwide in US", "recall_number": "D-0847-2021", "product_description": "Neutrogena Ultra Sheer body mist sunscreen BROAD SPECTRUM SPF 30, Avobenzone (3%), Homosalate (8%), Octisalate (5%), Octocrylene (8%), Net Wt. 8.0 oz. (226 g) aerosol can, Distributed by: JOHNSON & JOHNSON CONSUMER, INC. Skillman, NY 08858 UPC 0 86800 11133 7", "product_quantity": "196,380 cans", "reason_for_recall": "cGMP Deviations", "recall_initiation_date": "20210714", "center_classification_date": "20210924", "report_date": "20211006", "code_info": "All lots within expiry"}, {"status": "Terminated", "city": "Mesa", "state": "AZ", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "83669", "recalling_firm": "First Royal Care Co. LLC, dba Red Mountain Compounding Pharmacy", "address_1": "6828 E Brown Rd Ste 101", "address_2": "N/A", "postal_code": "85207-3761", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA", "recall_number": "D-0231-2020", "product_description": "S-HYDROXYPROG CAPROATE 250MG/ML IN SESAME OIL INJ, 5ML glass vial, Red Mountain Compounding Rx", "product_quantity": "1x5 ml vial", "reason_for_recall": "Lack of Assurance of Sterility", "recall_initiation_date": "20190812", "center_classification_date": "20191105", "termination_date": "20230413", "report_date": "20191113", "code_info": "Lot #: S06192019DT@09, Exp 9/19/19;"}, {"status": "Terminated", "city": "Greenville", "state": "SC", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA203621"], "brand_name": ["NYSTATIN"], "generic_name": ["NYSTATIN"], "manufacturer_name": ["Pharmaceutical Associates, Inc."], "product_ndc": ["0121-0810", "0121-4810"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["NYSTATIN"], "rxcui": ["312055"], "spl_id": ["d57cde69-0eb9-180d-e053-2995a90a33aa"], "spl_set_id": ["31e3da10-5a7b-4bc5-8a4f-3e786b64c13a"], "package_ndc": ["0121-0810-02", "0121-0810-16", "0121-4810-05", "0121-4810-40", "0121-4810-00", "0121-4810-50"], "is_original_packager": [true], "upc": ["0301210810022"], "nui": ["N0000175498", "M0017172"], "pharm_class_epc": ["Polyene Antifungal [EPC]"], "pharm_class_cs": ["Polyenes [CS]"], "unii": ["BDF1O1C72E"]}, "product_type": "Drugs", "event_id": "85302", "recalling_firm": "PAI Holdings, LLC. dba Pharmaceutical Associates Inc", "address_1": "1700 Perimeter Rd", "address_2": "N/A", "postal_code": "29605-5252", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA.", "recall_number": "D-1060-2020", "product_description": "Nystatin Oral Suspension, USP, 100,000 units per mL, Cherry/Peppermint Flavor, 16 fl oz (473 mL) bottle, Rx ONLY, pai Pharmaceutical Associates, Inc., Greenville, SC  29605; NDC 0121-0810-16.", "product_quantity": "7416 bottles", "reason_for_recall": "SubPotent Drug: Low out-of-specification results for assay testing.", "recall_initiation_date": "20200319", "center_classification_date": "20200325", "termination_date": "20210922", "report_date": "20200401", "code_info": "Lot: BE85, Exp. 11/2020", "more_code_info": ""}, {"status": "Terminated", "city": "Sterling", "state": "VA", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "91443", "recalling_firm": "Northern VA Compounders PLLC", "address_1": "23475 Rock Haven Way", "address_2": "Suite 105", "postal_code": "20166-4444", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit", "distribution_pattern": "Nationwide in the USA", "recall_number": "D-0114-2023", "product_description": "TriMix Injection (PGE1/Papaverine HCl/Phentolamine Mesylate) 40mcg/30mg/2mg/mL INJECTABLE, 2.5 mL Multiple-Dose vials, Rx Only, Compounded by: Akina Pharmacy, 23475 Rock Haven Way Suite 105, Sterling, VA  20166.", "product_quantity": "4 vials", "reason_for_recall": "Lack of Assurance of Sterility", "recall_initiation_date": "20221230", "center_classification_date": "20230112", "termination_date": "20230621", "report_date": "20230118", "code_info": "Lot#: 11142022@11, Exp 12/29/2022", "more_code_info": ""}, {"status": "Terminated", "city": "Winter Park", "state": "FL", "country": "United States", "classification": "Class I", "openfda": {}, "product_type": "Drugs", "event_id": "70317", "recalling_firm": "Anabolic Science Labs, LLC", "address_1": "900 S Kentucky Ave", "address_2": "N/A", "postal_code": "32789-4751", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "US Nationwide and Singapore", "recall_number": "D-0985-2015", "product_description": "M14-MENT ADVANCED MASS BUILDER (7a-Methyl-estra-4-en-3,17-dione MENT 5mg, M14D 20 mg), Capsules, 90 count bottle, Manufactured for: Wyked Labs LLC, Winter Park, FL 32789", "product_quantity": "1,479 bottles", "reason_for_recall": "Marketed without an approved NDA/ANDA  - These products are being recalled due to the presence of synthetic hormone/prohormone (methylated anabolic steroid) ingredient making them unapproved new drugs.", "recall_initiation_date": "20141212", "center_classification_date": "20150505", "termination_date": "20170208", "report_date": "20150513", "code_info": "All lots"}, {"status": "Ongoing", "city": "Carolina", "state": "PR", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "93159", "recalling_firm": "Omega & Delta Co., Inc.", "address_1": "Carr. 887 Km 0 Hm 8 Julio N. Matos Ind. Park Bldg#10", "address_2": "N/A", "postal_code": "00985", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "E-Mail", "distribution_pattern": "Distributed in Puerto Rico only.", "recall_number": "D-0103-2024", "product_description": "DOP Instant Hand Sanitizer (Ethyl Alcohol 65%) with Moisturizers, Original, 4FL OZ (118 ml) bottle, Hecho en Puerto Rico por: Omega & Delta Co., Inc. UPC 7 42699 00027 4", "product_quantity": "48,145 4 oz bottles", "reason_for_recall": "Sub Potent and Super Potent Product: During an impact assessment of the DOP Hand Sanitizer product, it was identified that several lots distributed did not comply with the finished good acceptance criteria established.", "recall_initiation_date": "20231020", "center_classification_date": "20231114", "report_date": "20231122", "code_info": "Lot #s  1327034, 1328034, 1277029, 1278029, 1202015, 1203015, 0246097, 0247097, 0247099, 0248099, 0252099"}, {"status": "Terminated", "city": "Hastings", "state": "NE", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "85081", "recalling_firm": "Redline Pharmacy Solutions", "address_1": "2415 Osborne Dr E Ste 100", "address_2": "", "postal_code": "68901-1999", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Telephone", "distribution_pattern": "Sold to patients in Nebraska", "recall_number": "D-1006-2020", "product_description": "Acetylcysteine Ophthalmic 10% Solution, 5 mL per dropper bottle (10ML).  Redline Specialty Pharmacy, 2415 Osborne Drive E, #100 Hastings, NE 68901", "product_quantity": "2x5 ml bottles", "reason_for_recall": "Lack Of Processing Controls", "recall_initiation_date": "20200224", "center_classification_date": "20200312", "termination_date": "20220331", "report_date": "20200318", "code_info": "Lot 02242020@1", "more_code_info": ""}, {"country": "United States", "city": "Vancouver", "address_1": "14301 Se 1st St", "reason_for_recall": "Labeling: Label Mixup; PSEUDOEPHEDRINE HCL, Tablet, 30 mg may be potentially mislabeled as     D-ALPHA TOCOPHERYL ACETATE, Capsule, 400 units, NDC 49348041010, Pedigree: AD52993_28, EXP: 5/20/2014.", "address_2": "", "product_quantity": "100 Tablets", "code_info": "PSEUDOEPHEDRINE HCL, Tablet, 30 mg has the following code    Pedigree: AD52993_37, EXP: 5/20/2014.", "center_classification_date": "20140116", "distribution_pattern": "Repacked drugs were distributed in Arizona, California, Oregon, and Washington.", "state": "WA", "product_description": "PSEUDOEPHEDRINE HCL, Tablet, 30 mg, Rx in Oregon, Distributed by: AidaPak Service, LLC, NDC 00904505360", "report_date": "20140122", "classification": "Class II", "openfda": {}, "recalling_firm": "Aidapak Services, LLC", "recall_number": "D-469-2014", "initial_firm_notification": "Telephone", "product_type": "Drugs", "event_id": "65707", "termination_date": "20140207", "more_code_info": "", "recall_initiation_date": "20130702", "postal_code": "98684-3501", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Terminated", "city": "Biloxi", "state": "MS", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "79671", "recalling_firm": "Coastal Meds, LLC.", "address_1": "1759 Medical Park Dr Ste C", "address_2": "N/A", "postal_code": "39532-2154", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "E-Mail", "distribution_pattern": "Nationwide in the USA", "recall_number": "D-0718-2018", "product_description": "ADENO-PLEX Injectable-30 mL MDV. Coastal Meds LLC 1759 Medical Park Dr., Ste C Bioloxi, MS 39532", "product_quantity": "200 vials", "reason_for_recall": "Presence of Particulate matter. Recall due to presence of unknown particulate matter.", "recall_initiation_date": "20180405", "center_classification_date": "20180509", "termination_date": "20201124", "report_date": "20180502", "code_info": "Lot: AP/011218 Discard by 7/11/2018"}, {"status": "Terminated", "city": "Woburn", "state": "MA", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "72948", "recalling_firm": "Safecor Health, LLC", "address_1": "317 New Boston St", "address_2": "N/A", "postal_code": "01801-6231", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "NY", "recall_number": "D-0785-2016", "product_description": "Phenobarbital/Hyoscyamine/ Atropine/Scopolamine 16.2/0.1037/0.0194/0.0065 mg  DONNATAL ELIXIR, 5 ml Cup grape, Alcohol 23.8%, Rx Only, MFG: Concordia, PKG BY: SAFECOR HEALTH, WOBURN, MA, C5921242304.", "product_quantity": "23 cups", "reason_for_recall": "Labeling: Label Error on Declared Strength: Label incorrectly identifies product dose as 5ml instead of 10 ml.", "recall_initiation_date": "20150716", "center_classification_date": "20160329", "termination_date": "20160330", "report_date": "20160406", "code_info": "Lot #: 914227; Exp 06/16"}, {"status": "Terminated", "city": "Pennington", "state": "NJ", "country": "United States", "classification": "Class III", "openfda": {}, "product_type": "Drugs", "event_id": "73221", "recalling_firm": "Zydus Pharmaceuticals USA Inc", "address_1": "73 Route 31 N", "address_2": "N/A", "postal_code": "08534-3601", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "US Nationwide including Puerto Rico", "recall_number": "D-0725-2016", "product_description": "risperiDONE ORALLY DISINTEGRATING TABLETS, 2 mg, 30 Ct Bottles, Rx Only. Manufactured by: Cadila Healthcare Ltd., Ahmedabad, India.  Distributed by: Zydus Pharmaceuticals USA Inc. Pennington, NJ  08534. NDC: 68382-156-06.", "product_quantity": "9504 Bottles", "reason_for_recall": "Failed Impurities/Degradation Specifications: Out of specification for a known degradant.", "recall_initiation_date": "20160114", "center_classification_date": "20160222", "termination_date": "20201218", "report_date": "20160302", "code_info": "Lot #: MP4967, Expiry: 04/2016.", "more_code_info": ""}, {"status": "Terminated", "city": "Morrow", "state": "GA", "country": "United States", "classification": "Class III", "openfda": {}, "product_type": "Drugs", "event_id": "63395", "recalling_firm": "Abc Compounding Company Inc", "address_1": "6970 Jonesboro Rd", "address_2": "N/A", "postal_code": "30260", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit", "distribution_pattern": "Nationwide", "recall_number": "D-011-2013", "product_description": "Earth Force, Ltd., Power Towels, QS Plus Hand Sanitizing Wipes (antiseptic), 50 pre-moistened Wipes, Manufactured by: ABC Compounding Co., Inc., P.O. Box 16247, Atlanta, GA 30321.", "product_quantity": "66 rolls of wipes", "reason_for_recall": "Chemical Contamination: QS Plus wipes were found to be contaminated with different substance (7820, Graffiti Remover).", "recall_initiation_date": "20110210", "center_classification_date": "20121022", "termination_date": "20121030", "report_date": "20121031", "code_info": "Lot #3220"}, {"status": "Terminated", "city": "Windsor", "state": "CT", "country": "United States", "classification": "Class III", "openfda": {}, "product_type": "Drugs", "event_id": "86990", "recalling_firm": "SCA Pharmaceuticals", "address_1": "755 Rainbow Rd Ste B", "address_2": "", "postal_code": "06095-1024", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Product was distributed to hospitals nationwide.", "recall_number": "D-0201-2021", "product_description": "Morphine Sulfate 3 mg/3 mL in 0.9% Sodium Chloride (1mg/mL) CII, Rx Only, 3 ml Single Dose Syringe, SCA Pharmaceuticals, 755 Rainbow Rd., Windsor, CT, 06095, barcode 70004010025", "product_quantity": "751 syringes", "reason_for_recall": "Lack of Assurance of Sterility; potential for a defective syringe cap, resulting in a non-integral unit", "recall_initiation_date": "20201217", "center_classification_date": "20210107", "termination_date": "20211102", "report_date": "20210113", "code_info": "Lot # 1220023452, BUD 2/7/2021", "more_code_info": ""}, {"status": "Terminated", "city": "Baltimore", "state": "MD", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA065259"], "brand_name": ["CEFDINIR"], "generic_name": ["CEFDINIR"], "manufacturer_name": ["Lupin Pharmaceuticals, Inc."], "product_ndc": ["68180-722", "68180-723"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["CEFDINIR"], "rxcui": ["309054", "476576"], "spl_id": ["b32b7bfb-4770-4da0-8c48-684233cd10c9"], "spl_set_id": ["7490df67-56c0-4a1c-8533-2107f3e8aea5"], "package_ndc": ["68180-722-20", "68180-722-10", "68180-722-04", "68180-722-05", "68180-723-20", "68180-723-10", "68180-723-04", "68180-723-05"], "is_original_packager": [true], "upc": ["0368180723042"], "nui": ["N0000175488", "M0003827"], "pharm_class_epc": ["Cephalosporin Antibacterial [EPC]"], "pharm_class_cs": ["Cephalosporins [CS]"], "unii": ["CI0FAO63WC"]}, "product_type": "Drugs", "event_id": "82939", "recalling_firm": "Lupin Pharmaceuticals Inc.", "address_1": "111 S Calvert St Fl 21ST", "address_2": "N/A", "postal_code": "21202-6174", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Distributed Nationwide in the USA", "recall_number": "D-1320-2019", "product_description": "Cefdinir for Oral Suspension USP, 250mg/5mL, Powder for oral suspension, 60 mL bottle, Rx only, Manufactured for: Lupin Pharmaceuticals, Inc., Baltimore, Maryland 20201, Manufactured by: Lupin Limited, Mandideep 462 046 India. NDC 68180-723-20", "product_quantity": "18,408, 60 mL bottles", "reason_for_recall": "Complaint received of metal piece identified in the product bottle prior to the reconstitution.", "recall_initiation_date": "20190523", "center_classification_date": "20190530", "termination_date": "20201022", "report_date": "20190605", "code_info": "Lot # F802335, exp. date November 2020"}, {"country": "United States", "city": "Birmingham", "address_1": "6801 Cahaba Valley Rd Ste 116", "reason_for_recall": "Lack of Assurance of Sterility", "address_2": "", "product_quantity": "250 mL  in Vials", "code_info": "Lot #: 151214-62, BUD: 06/11/16", "center_classification_date": "20160708", "distribution_pattern": "U.S. Nationwide, Japan, and New Zealand.", "state": "AL", "product_description": "FOLIC ACID 10MG/ML IN NACL (PF), 1ML Vials, MEDAUS PHARMACY", "report_date": "20160720", "classification": "Class II", "openfda": {}, "recalling_firm": "Medaus, Inc.", "recall_number": "D-1184-2016", "initial_firm_notification": "E-Mail", "product_type": "Drugs", "event_id": "74466", "termination_date": "20170616", "more_code_info": "", "recall_initiation_date": "20160513", "postal_code": "35242-9609", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Ongoing", "city": "Nicholasville", "state": "KY", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "89909", "recalling_firm": "TMC Acquisition LLC dba Tailor Made Compounding", "address_1": "200 Moore Dr", "address_2": "", "postal_code": "40356-8512", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide USA and Puerto Rico", "recall_number": "D-1217-2022", "product_description": "Methylcobalamin Preservative Free, 10mg/mL, 1mL-vial,  Room Temperature, Tailor Made Compounding", "product_quantity": "4 vials", "reason_for_recall": "Lack of Assurance of Sterility", "recall_initiation_date": "20220307", "center_classification_date": "20220714", "report_date": "20220720", "code_info": "Batch#: 03012234A1, Exp 8/28/2022.", "more_code_info": ""}, {"status": "Terminated", "city": "Southern Pines", "state": "NC", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "70656", "recalling_firm": "Health Innovations Pharmacy, Inc", "address_1": "295 Pinehurst Ave Bldg 2", "address_2": "N/A", "postal_code": "28387-7051", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit", "distribution_pattern": "NC", "recall_number": "D-1059-2015", "product_description": "Cyclandelate 200 mg Caps, Health Innov Pharmacy, 295 Pinehurst Ave, Southern Pines, NC 28387, (910) 246-5155", "product_quantity": "N/A", "reason_for_recall": "Lack of Assurance of Sterility and Stability Data does not Support Expiry: recent inspection observations associated with certain quality control procedures that present a risk to sterility and quality assurance.", "recall_initiation_date": "20150212", "center_classification_date": "20150508", "termination_date": "20170720", "report_date": "20150520", "code_info": "All lots", "more_code_info": ""}, {"status": "Completed", "city": "Aquebogue", "state": "NY", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "83265", "recalling_firm": "Altaire Pharmaceuticals, Inc.", "address_1": "311 W Ln", "address_2": "PO Box 849", "postal_code": "11931-0849", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit", "distribution_pattern": "U.S.A. Nationwide", "recall_number": "D-0410-2020", "product_description": "CVS Health Maximum Redness Relief Lubricant Redness Reliever Eye Drops, Sterile, 0.5 fl. oz., (15 mL), Item #994880, Distributed by: CVS Pharmacy Inc., One CVS Drive, Woonsocket, RI 02895", "product_quantity": "483,528 units", "reason_for_recall": "Lack of Assurance of Sterility", "recall_initiation_date": "20190702", "center_classification_date": "20191115", "report_date": "20191127", "code_info": "17251 8/19   17269 9/19   17360 12/19   18012 1/20   18106 4/20   18275 11/20   18275 11/20"}, {"status": "Terminated", "city": "Melville", "state": "NY", "country": "United States", "classification": "Class III", "openfda": {"application_number": ["ANDA085692"], "brand_name": ["TRIAMCINOLONE ACETONIDE"], "generic_name": ["TRIAMCINOLONE ACETONIDE"], "manufacturer_name": ["E. Fougera & Co. a division of Fougera Pharmaceuticals Inc."], "product_ndc": ["0168-0002", "0168-0003", "0168-0004"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["TOPICAL"], "substance_name": ["TRIAMCINOLONE ACETONIDE"], "rxcui": ["1014314", "1085644", "1085686"], "spl_id": ["719f34d8-deb8-446f-a201-3f74fed4e831"], "spl_set_id": ["92a1ded0-8e1a-4994-9c8a-89e84fc85c94"], "package_ndc": ["0168-0003-15", "0168-0003-80", "0168-0004-15", "0168-0004-80", "0168-0004-16", "0168-0002-15"], "is_original_packager": [true], "upc": ["0301680003153", "0301680002156", "0301680004150", "301680004808"], "nui": ["N0000175576", "N0000175450"], "pharm_class_epc": ["Corticosteroid [EPC]"], "pharm_class_moa": ["Corticosteroid Hormone Receptor Agonists [MoA]"], "unii": ["F446C597KA"]}, "product_type": "Drugs", "event_id": "67329", "recalling_firm": "Fougera Pharmaceuticals  Inc.", "address_1": "60 Baylis Rd", "address_2": "N/A", "postal_code": "11747-3838", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide.", "recall_number": "D-1152-2014", "product_description": "Triamcinolone Acetonide Cream USP, 0.1%, Net Wt 80 grams per tube, Rx only, E. Fougera & Co., A division of Fougera Pharmaceuticals Inc., Melville, New York  11747, NDC 0168-0004-80, UPC 3 0168-0004-80 8.", "product_quantity": "493,192 tubes", "reason_for_recall": "Labeling: Label Error on Declared Strength: There is a misprint on the end flap which read 01% rather than 0.1%.", "recall_initiation_date": "20140129", "center_classification_date": "20140307", "termination_date": "20151208", "report_date": "20140319", "code_info": "Lot #: 485P, 486P, 487P, 488P, Exp 06/15; 638P, 639P, 640P, Exp 07/15; 753P, 754P, 755P, Exp 08/15; 898P, 756P, 757P, 758P, 899P, 900P, 901P, 902P, Exp 09/15"}, {"status": "Terminated", "city": "Bristol", "state": "TN", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "82554", "recalling_firm": "Anderson Compounding Pharmacy, Inc. DBA Anderson Compounding Pharmacy", "address_1": "Attn: Cleve Anderson", "address_2": "310 Bluff City Hwy", "postal_code": "37620-4602", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide", "recall_number": "D-1189-2019", "product_description": "EDTA 1% Sterile Injection (Preservative Free), Anderson Compounding Pharmacy 310 Bluff City Hwy, Bristol, TN.", "product_quantity": "N/A", "reason_for_recall": "Lack of sterility assurance.", "recall_initiation_date": "20190402", "center_classification_date": "20190418", "termination_date": "20210924", "report_date": "20190424", "code_info": "All Lots"}, {"status": "Terminated", "city": "Lake Forest", "state": "IL", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "74057", "recalling_firm": "Pharmedium Services, LLC", "address_1": "150 N Field Dr Ste 350", "address_2": "N/A", "postal_code": "60045-2506", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "E-Mail", "distribution_pattern": "Nationwide", "recall_number": "D-1406-2016", "product_description": "2.5 mcg/mL Fentanyl Citrate and 0.125% Bupivacaine HCl (Preservative Free) in 0.9% Sodium Chloride, 100 mL in 100 mL Smiths Medical Cassette, flow stop free flow protection, Service Code 2K8972, Rx Only,  Compounded by PharMEDium Services, LLC, Memphis, TN 36141, NDC 61553-0972-48", "product_quantity": "220 Medical Cassettes", "reason_for_recall": "Presence of Particulate Matter: API contaminated with glass particulate was used to produce sterile injectable drugs.", "recall_initiation_date": "20160505", "center_classification_date": "20160716", "termination_date": "20180306", "report_date": "20160727", "code_info": "Service Code 2K8210 , Lot Number 160390175M , Exp. Date 5/9/2016 ;  Service Code 2K8210 , Lot Number 160400226M , Exp. Date 5/10/2016 ;  Service Code 2K8210 , Lot Number 160520170M , Exp. Date 5/22/2016 ;  Service Code 2K8210 , Lot Number 160590066M , Exp. Date 5/29/2016 ;  Service Code 2K8210 , Lot Number 160670046M , Exp. Date 6/5/2016 ;  Service Code 2K8210 , Lot Number 160680006M , Exp. Date 6/6/2016 ;  Service Code 2K8210 , Lot Number 160700027M , Exp. Date 6/8/2016 ;  Service Code 2K8210 , Lot Number 160730069M , Exp. Date 6/11/2016 ;  Service Code 2K8210 , Lot Number 160880217M , Exp. Date 6/27/2016 ;  Service Code 2K8972 , Lot Number 160450177M , Exp. Date 5/6/2016 ;  Service Code 2K8972 , Lot Number 160460196M , Exp. Date 5/7/2016 ;  Service Code 2K8972 , Lot Number 160600082M , Exp. Date 5/20/2016 ;  Service Code 2K8972 , Lot Number 160670061C , Exp. Date 5/28/2016 ;  Service Code 2K8972 , Lot Number 160740067C , Exp. Date 6/4/2016 ;  Service Code 2K8972 , Lot Number 160810085C , Exp. Date 6/11/2016 ;  Service Code 2K8972 , Lot Number 160950188M , Exp. Date 6/25/2016 ;", "more_code_info": ""}, {"status": "Terminated", "city": "Camarillo", "state": "CA", "country": "United States", "classification": "Class III", "openfda": {}, "product_type": "Drugs", "event_id": "73152", "recalling_firm": "Golden State Medical Supply Inc.", "address_1": "5187 Camino Ruiz", "address_2": "N/A", "postal_code": "93012-8601", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide", "recall_number": "D-0768-2016", "product_description": "Atorvastatin Calcium 20 mg, 10 tablets per blister,100-count package, Rx Only  Manufactured by Apotex Inc. Toronto, Ontario, Canada, Packaged by GSMS Inc., Camarillo, CA 93010, NDC # 60429-324-77", "product_quantity": "74 100-count packages (7,400 tablets)", "reason_for_recall": "Failed Impurities/Degradation Specifications", "recall_initiation_date": "20160127", "center_classification_date": "20160309", "termination_date": "20160628", "report_date": "20160316", "code_info": "Lot #GS008856; Exp. 09/17  Lot #GS010268; Exp. 09/17  Lot #GS010600; Exp. 11/17"}, {"status": "Terminated", "city": "Charlotte", "state": "NC", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "82620", "recalling_firm": "CMC Enterprise Pharmacy", "address_1": "4400 Golf Acres Dr", "address_2": "N/A", "postal_code": "28208-5968", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "NC", "recall_number": "D-1220-2019", "product_description": "Alteplase 1 mg/mL 1 mL in 10 mL syringe, Made by: Enterprise Pharmacy, 4400 Golf Acres Drive, Bldg. J Suite E, Charlotte, NC, 28208.", "product_quantity": "97 syringes", "reason_for_recall": "Lack of sterility assurance.", "recall_initiation_date": "20190412", "center_classification_date": "20190423", "termination_date": "20191030", "report_date": "20190501", "code_info": "Lots: ED021901 Exp. 5/17/2019; ED031921 Exp. 5/18/2019"}, {"status": "Terminated", "city": "Wilmington", "state": "MA", "country": "United States", "classification": "Class III", "openfda": {}, "product_type": "Drugs", "event_id": "75490", "recalling_firm": "CutisPharma, Inc.", "address_1": "841 Woburn St", "address_2": "N/A", "postal_code": "01887-3414", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide", "recall_number": "D-0138-2017", "product_description": "FIRST Omeprazole 2mg/mL in FIRST  PPI Suspension Compounding Kit , 5 oz., Rx only, Manufactured for CutisPharma Wilmington, MA, NDC# 65628-070-05", "product_quantity": "8,748 kits", "reason_for_recall": "Labeling: Label error on declared strength. Package Insert -Error in the Description section of the package insert refers to the strength as 3mg per mL; however it should state 2mg per mL", "recall_initiation_date": "20161020", "center_classification_date": "20161116", "termination_date": "20170912", "report_date": "20161123", "code_info": "Lot #: E1414, Exp. 08/2018"}, {"country": "United States", "city": "Ocala", "address_1": "202 SW 17th St Suite C", "reason_for_recall": "Lack of Assurance of Sterility; All lots of sterile products compounded by the pharmacy within expiry are subject to this recall. This recall is initiated due to concerns associated with quality control procedures observed during a recent FDA inspection.", "address_2": "", "product_quantity": "5 units", "code_info": "Rx 29162 Exp. 5/21/2014", "center_classification_date": "20140724", "distribution_pattern": "Florida", "state": "FL", "product_description": "Nafcillin 12 gm/300 mL, Trinity Care Solutions, 202-C SW 17th Street, Ocala, FL 34471-5138, For Parenteral Use Only, Rx # 29162, Discard After 05/21/14", "report_date": "20140730", "classification": "Class II", "openfda": {}, "recalling_firm": "Franck's Lab Inc dba Trinity Care Solutions", "recall_number": "D-1462-2014", "initial_firm_notification": "Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit", "product_type": "Drugs", "event_id": "68497", "more_code_info": "", "recall_initiation_date": "20140515", "postal_code": "34471-8138", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Ongoing"}, {"country": "United States", "city": "Henderson", "address_1": "1850 Whitney Mesa Dr", "reason_for_recall": "Lack of Assurance of Sterility: all sterile products compounded, repackaged, and distributed by this compounding pharmacy due to lack of sterility assurance and concerns associated with the quality control processes.", "address_2": "Suite 180", "product_quantity": "5 vials", "code_info": "Lot #: a) Nandrolone 100 mg/mL TestCyp 100 mg/mL 10 mL: 130220060AE, Exp 5/20/13", "center_classification_date": "20130516", "distribution_pattern": "Nationwide", "state": "NV", "product_description": "Nandrolone Decanoate and Testosterone Cypionate Injection, all strengths and all presentations including a) Nandrolone 100 mg/mL TestCyp 100 mg/mL 10 mL and b) Nandrolone 100 mg/mL TestCyp 200 mg/mL 10 mL, Rx only, Green Valley Drugs, 1850 Whitney Mesa, #180, Henderson, NV  89014.", "report_date": "20130522", "classification": "Class II", "openfda": {}, "recalling_firm": "FVS Holdings, Inc. dba. Green Valley Drugs", "recall_number": "D-406-2013", "initial_firm_notification": "Press Release", "product_type": "Drugs", "event_id": "64879", "termination_date": "20140321", "more_code_info": "", "recall_initiation_date": "20130410", "postal_code": "89014-2091", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Terminated", "city": "South Beloit", "state": "IL", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "77732", "recalling_firm": "Precision Dose Inc.", "address_1": "722 Progressive Ln", "address_2": "N/A", "postal_code": "61080-2616", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Telephone", "distribution_pattern": "OH and CT", "recall_number": "D-1037-2017", "product_description": "Carbamazepine Oral Suspension, USP. 100 mg/5 mL, 5 mL Unit Dose Cups, Rx Only, Pkg: Precision Dose, Inc., S. Beloit, IL 61080, NDC 68094-301-59.", "product_quantity": "480 (5mL) unit dose cups", "reason_for_recall": "Labeling Error: Label mix-up.  Products' unit dose cups are correctly labeled, but the product carton lists incorrect volume and NDC.", "recall_initiation_date": "20170705", "center_classification_date": "20170731", "termination_date": "20180328", "report_date": "20170809", "code_info": "Lot #: 500326, Exp. 6/30/2018"}, {"country": "United States", "city": "Birmingham", "address_1": "6801 Cahaba Valley Rd Ste 116", "reason_for_recall": "Lack of Assurance of Sterility", "address_2": "", "product_quantity": "1000 mL in Vials", "code_info": "Lot #: 151130-85, BUD:  05/26/16", "center_classification_date": "20160708", "distribution_pattern": "U.S. Nationwide, Japan, and New Zealand.", "state": "AL", "product_description": "LIPO-INJECTION W/LIDOCAINE (PF), ASCORBIC ACID 50MG; B1-50MG; B2-5-PO4-5MG; B3-50MG B5-5MG, B6-5MG, CYANO B-12-100MCG, METHIONINE 12.5 MG, INOSITOL 25 MG, CHOLINE CL-25 MG, LIDCAINE 10 MG/ML, 2ML Vials, MEDAUS PHARMACY", "report_date": "20160720", "classification": "Class II", "openfda": {}, "recalling_firm": "Medaus, Inc.", "recall_number": "D-1203-2016", "initial_firm_notification": "E-Mail", "product_type": "Drugs", "event_id": "74466", "termination_date": "20170616", "more_code_info": "", "recall_initiation_date": "20160513", "postal_code": "35242-9609", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"country": "United States", "city": "Ocala", "address_1": "1210 SW 33rd Avenue", "reason_for_recall": "Lack of Assurance of Sterility: Franck's Lab Inc. initiated a recall of all Sterile Human Drugs distributed between 11/21/2011 and 05/21/2012 because FDA environmental sampling revealed the presence of microorganisms and fungal growth in the clean room where sterile products were prepared.", "address_2": "", "product_quantity": "2 units", "code_info": "Rx #'s:   0397185    0408097", "center_classification_date": "20120810", "distribution_pattern": "Nationwide, Bahamas, Columbia, Dominican Republic, Grand Cayman, Guatemala, Poland, Santo Domingo, Venezuela, and West Indies", "state": "FL", "product_description": "EDETATE DISODIUM PF IN BSS 3% OPHTHALMIC 10 ML; EDETATE DISODIUM SOLUTION IN ARTIFICIAL TEARS 0.05% OPHTHALMIC 10 ML (2 DIFFERENT PRODUCTS)", "report_date": "20120822", "classification": "Class II", "openfda": {}, "recalling_firm": "Franck's Lab Inc., d.b.a. Franck's Compounding Lab", "recall_number": "D-1511-2012", "initial_firm_notification": "Letter", "product_type": "Drugs", "event_id": "62416", "termination_date": "20140813", "more_code_info": "", "recall_initiation_date": "20120525", "postal_code": "34474-5138", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Terminated", "city": "East Windsor", "state": "NJ", "country": "United States", "classification": "Class III", "openfda": {"application_number": ["ANDA206242"], "brand_name": ["MOXIFLOXACIN"], "generic_name": ["MOXIFLOXACIN"], "manufacturer_name": ["Aurobindo Pharma Limited"], "product_ndc": ["65862-840"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["OPHTHALMIC"], "substance_name": ["MOXIFLOXACIN HYDROCHLORIDE"], "rxcui": ["403818"], "spl_id": ["95a06b0b-fd23-4b1b-9813-105678b10b6c"], "spl_set_id": ["8877013d-9b49-40f7-a2c4-99bb519e104e"], "package_ndc": ["65862-840-03"], "is_original_packager": [true], "upc": ["0365862840035"], "unii": ["C53598599T"]}, "product_type": "Drugs", "event_id": "84498", "recalling_firm": "AuroMedics Pharma LLC", "address_1": "279 Princeton Hightstown Rd", "address_2": "", "postal_code": "08520-1401", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the U.S.", "recall_number": "D-0789-2020", "product_description": "Moxifloxacin Ophthalmic Solution USP, 0.5%, Sterile, 3mL Bottle, Rx Only, For Topical Ophthalmic Use Only, Distributed by: Aurobindo Pharma USA, Inc., East Windsor, NJ 08520, Made in India, NDC 65862-840-03.", "product_quantity": "100,080 bottles", "reason_for_recall": "Discoloration: Market complaints of discoloration in Moxifloxacin Ophthalmic Solution.", "recall_initiation_date": "20191202", "center_classification_date": "20200117", "termination_date": "20221122", "report_date": "20200122", "code_info": "Lot #s: CMF190008; CMF190009, Exp. 04/2021; CMF190025; CMF190026, Exp. 06/2021.", "more_code_info": ""}, {"status": "Terminated", "city": "Star", "state": "ID", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "64619", "recalling_firm": "Palmer Natural Products", "address_1": "11665 W State St", "address_2": "N/A", "postal_code": "83669-5223", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit", "distribution_pattern": "Florida, Idaho, California and Hong Kong.  This product can be ordered on line.", "recall_number": "D-233-2013", "product_description": "Piracetam & Choline, 390mg Piracetam 104mg Choline Capsules, a) 30 count bottle, b) 100 count bottle, OTC, BoostYourGrade, LLC, Orlando, FL. 32826    ,", "product_quantity": "511 30 count bottles, 4103 100 count bottles", "reason_for_recall": "Marketed Without an Approved NDA/ANDA: The products are unapproved drugs", "recall_initiation_date": "20130311", "center_classification_date": "20130401", "termination_date": "20130807", "report_date": "20130410", "code_info": "All lot codes."}, {"status": "Terminated", "city": "Mahwah", "state": "NJ", "country": "United States", "classification": "Class III", "openfda": {"application_number": ["ANDA210809"], "brand_name": ["CLOBETASOL PROPIONATE"], "generic_name": ["CLOBETASOL PROPIONATE"], "manufacturer_name": ["Glenmark Pharmaceuticals Inc., USA"], "product_ndc": ["68462-608"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["TOPICAL"], "substance_name": ["CLOBETASOL PROPIONATE"], "rxcui": ["861353"], "spl_id": ["9e397c0b-af80-45db-a7d6-232077c35622"], "spl_set_id": ["db8c7a36-e950-44b9-b2ff-7fede2e87407"], "package_ndc": ["68462-608-94", "68462-608-27"], "is_original_packager": [true], "unii": ["779619577M"]}, "product_type": "Drugs", "event_id": "84282", "recalling_firm": "Glenmark Pharmaceuticals Inc., USA", "address_1": "750 Corporate Dr", "address_2": "N/A", "postal_code": "07430-2009", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide", "recall_number": "D-0618-2020", "product_description": "Clobetasol Propionate Foam, 0.05%, a) 50 g pack (NDC 68462-608-27) and b) 100 g pack (NDC 68462-608-94), Rx only,   Manufactured by: Glenmark Pharmaceuticals  Ltd. Plot No.: B-25, MIDC, Shendra Aurangabad - 431210, Maharashtra, India Manufactured for: Glenmark Pharmaceuticas Inc. USA Mahwah, NJ 07430", "product_quantity": "a) 34521 bottles; b) 16930 bottles", "reason_for_recall": "Defective delivery system; product is not foaming or is coming out as liquid.", "recall_initiation_date": "20191115", "center_classification_date": "20191210", "termination_date": "20240315", "report_date": "20191218", "code_info": "a) 14190026, 14190028, 14190029, exp Feb-2021, 14190043, 14190045 exp Apr-2021    b) 14190024, 14190025, 14190027, exp Feb-2021, 14190030, 14190031, exp Mar-2021, 14190039, 14190042 exp Apr-2021, 14190047 exp May-2021, 14190062 exp Jul-2021", "more_code_info": ""}, {"country": "United States", "city": "Birmingham", "address_1": "6801 Cahaba Valley Rd Ste 116", "reason_for_recall": "Lack of Assurance of Sterility", "address_2": "", "product_quantity": "104 mL in Vials", "code_info": "a) Lot #: 160204-29, BUD: 08/02/16.  b) Lot #: 151123-73, BUD: 05/21/16;  Lot #: 151124-42, BUD: 05/22/16;  Lot #: 151201-20, BUD: 05/29/16;   Lot #: 151215-10, BUD: 06/12/16;  Lot #: 160229-46, BUD: 07/17/16;  Lot #: 160202-33, BUD: 07/31/16.  c) Lot #: 160315-9,                BUD: 09/11/16.", "center_classification_date": "20160708", "distribution_pattern": "U.S. Nationwide, Japan, and New Zealand.", "state": "AL", "product_description": "NIACINAMIDE 100 MG/ML (PF), In a) 1ML Vials, b) 5ML Vials, and c) 10ML Vials, MEDAUS PHARMACY", "report_date": "20160720", "classification": "Class II", "openfda": {}, "recalling_firm": "Medaus, Inc.", "recall_number": "D-1231-2016", "initial_firm_notification": "E-Mail", "product_type": "Drugs", "event_id": "74466", "termination_date": "20170616", "more_code_info": "", "recall_initiation_date": "20160513", "postal_code": "35242-9609", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Terminated", "city": "Dublin", "state": "OH", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["BLA020725"], "brand_name": ["CREON"], "generic_name": ["PANCRELIPASE"], "manufacturer_name": ["AbbVie Inc."], "product_ndc": ["0032-0045", "0032-1203", "0032-1206", "0032-1212", "0032-1224", "0032-3016", "0032-0046", "0032-0047", "0032-2636", "0032-2637"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["PANCRELIPASE AMYLASE", "PANCRELIPASE LIPASE", "PANCRELIPASE PROTEASE"], "rxcui": ["855495", "855499", "855503", "863829", "863836", "863841", "1113042", "1113046", "1373325", "1373327"], "spl_id": ["94463229-9296-4640-854f-41d76386d312"], "spl_set_id": ["073201aa-556d-4a70-918e-84e9616fd88d"], "package_ndc": ["0032-1203-70", "0032-1203-64", "0032-1206-07", "0032-1206-01", "0032-1206-56", "0032-1212-07", "0032-1212-01", "0032-1212-46", "0032-1212-13", "0032-1224-07", "0032-1224-01", "0032-1224-46", "0032-3016-28", "0032-3016-13", "0032-3016-50", "0032-3016-12", "0032-0045-70", "0032-0045-30", "0032-0046-30", "0032-0046-70", "0032-0047-30", "0032-0047-70", "0032-2636-70", "0032-2636-01", "0032-2636-30", "0032-2637-70", "0032-2637-01", "0032-2637-30"], "is_original_packager": [true], "upc": ["0300322637701", "0300320045706", "0300320047700", "0300320046703", "0300323016130", "0300322636704", "0300321224018"], "unii": ["3560D81V50", "YOJ58O116E", "8MYC33932O"]}, "product_type": "Drugs", "event_id": "87512", "recalling_firm": "Cardinal Health Inc.", "address_1": "7000 Cardinal Pl", "address_2": "N/A", "postal_code": "43017-1091", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "FL, GA, SC", "recall_number": "D-0402-2021", "product_description": "Creon (pancrelipase) Delayed-Release Capsules Dose By Lipase Units Lipase 36,000 USP Units Rx only NDC 0032-3016-13 100 Capsules Marketed by: AbbVie Inc. North Chicago, IL 60064, U.S.A.", "product_quantity": "1669 bottles", "reason_for_recall": "CGMP Deviations: Intermittent exposure to temperature excursion during storage.", "recall_initiation_date": "20210315", "center_classification_date": "20210524", "termination_date": "20240617", "report_date": "20210602", "code_info": "1139494"}, {"status": "Terminated", "city": "Canonsburg", "state": "PA", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "71218", "recalling_firm": "Mylan Lab Inc", "address_1": "1500 Corporate Dr Ste 400", "address_2": "N/A", "postal_code": "15317-8580", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide", "recall_number": "D-1111-2015", "product_description": "Mycophenolic Acid Delayed-release Tablets, 180 mg, 120-count bottle, Rx only, Mylan Pharmaceuticals, Inc., Morgantown, WV 26505 U.S.A., NDC 0378-4201-78, UPC 3 0378-4201-78 7.", "product_quantity": "7,722 bottles", "reason_for_recall": "Failed Dissolution Specifications: Low out of specification dissolution results.", "recall_initiation_date": "20150520", "center_classification_date": "20150529", "termination_date": "20161021", "report_date": "20150610", "code_info": "Lot #: 3059043, Exp 08/16"}, {"status": "Terminated", "city": "Little Rock", "state": "AR", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "77770", "recalling_firm": "SCA Pharmaceuticals", "address_1": "8821 Knoedl Ct", "address_2": "N/A", "postal_code": "72205-4600", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide", "recall_number": "D-1005-2017", "product_description": "BUPIVacaine HCl 0.1% PF (From 0.75%) in 0.9% Sodium Chloride, 250 mL Bag, Preservative Free (Waste From 250 mL Bag), Rx only, SCA Pharmaceuticals 8821 Knoedl Ct Little Rock, AR 72205 --- NDC# 70004-0060-40", "product_quantity": "N/A", "reason_for_recall": "Lack of Assurance of Sterility; product has the potential to leak.", "recall_initiation_date": "20170714", "center_classification_date": "20170726", "termination_date": "20190501", "report_date": "20170802", "code_info": "Lots: 20170429@33 BUD: 7/28/2017, 20170503@23 BUD: 8/1/2017"}, {"status": "Terminated", "city": "Titusville", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "71064", "recalling_firm": "Janssen Pharmaceuticals, Inc.", "address_1": "1125 Trenton-Harbourton Rd", "address_2": "N/A", "postal_code": "08560-1503", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "E-Mail", "distribution_pattern": "Nationwide and Canada", "recall_number": "D-1063-2015", "product_description": "Ortho-Cept (0.15 mg desogestrel and 0.03 mg ethinyl estradiol) tablets, 28- count blister (21 active tablets and 7 placebo tablets)/ 6 blister packs per carton. Rx only, Jointly Manufactured by: Janssen Ortho, LLC, Manati, Puerto Rico 00674 and NV Organon, Oss, The Netherlands, Manufactured for: Janssen Pharmaceuticals, Inc., Titusville, New Jersey 08560, New Jersey, NDC 50458-0196-15.", "product_quantity": "16,861 cartons/6 blister units (28 tablets) each", "reason_for_recall": "Subpotent Drug", "recall_initiation_date": "20150429", "center_classification_date": "20150511", "termination_date": "20180713", "report_date": "20150520", "code_info": "Lot # 13CM724, Exp.09/15 (US)  Lot # (L) 13DM732, Exp. 09/15 (Canada)", "more_code_info": ""}, {"status": "Terminated", "city": "Durham", "state": "NC", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA213424"], "brand_name": ["ATROPINE SULFATE"], "generic_name": ["ATROPINE SULFATE"], "manufacturer_name": ["Accord Healthcare Inc."], "product_ndc": ["16729-512"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ENDOTRACHEAL", "INTRAMEDULLARY", "INTRAMUSCULAR", "INTRAVENOUS", "SUBCUTANEOUS"], "substance_name": ["ATROPINE SULFATE"], "rxcui": ["1190776"], "spl_id": ["275def6c-5b2d-918b-e063-6294a90aa71f"], "spl_set_id": ["f3cb74e9-b4ac-4efe-bd8e-8a71970ee7c7"], "package_ndc": ["16729-512-05", "16729-512-43"], "is_original_packager": [true], "upc": ["0316729512053"], "unii": ["03J5ZE7KA5"]}, "product_type": "Drugs", "event_id": "92639", "recalling_firm": "Accord Healthcare, Inc.", "address_1": "1009 Slater Rd Ste 210B", "address_2": "N/A", "postal_code": "27703-8446", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide within the United States", "recall_number": "D-0917-2023", "product_description": "Atropine Sulfate Injection, USP 8 mg per 20 mL (0.4 mg per mL), 20 mL Multiple Dose Vials,  Rx only, Manufactured for: Accord Healthcare, Inc. Durham, NC 27703 Manufactured by: Intas Pharmaceuticals Limited Ahmedabad-382 210, India, NDC 16729-512-43.", "product_quantity": "2348 vials", "reason_for_recall": "Presence of Particulate Matter: Particulate matter identified as fiber.", "recall_initiation_date": "20230703", "center_classification_date": "20230713", "termination_date": "20241017", "report_date": "20230719", "code_info": "Lot #: M2210154 Exp. date 06/2025; M2212575 Exp. date 08/2025", "more_code_info": ""}, {"status": "Terminated", "city": "San Diego", "state": "CA", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "76472", "recalling_firm": "Synergy Rx", "address_1": "4901 Morena Blvd Ste 504A", "address_2": "N/A", "postal_code": "92117-7310", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Telephone", "distribution_pattern": "Nationwide within the United States", "recall_number": "D-0586-2017", "product_description": "HYDROQUINONE CREAM in all strengths including: 4%, 5%, 6%, 7%, 8%,10%, Rx only, Synergy RX, 4901 Morena Blvd # 504-A San Diego, CA 92117 (855) 792-6676", "product_quantity": "N/A", "reason_for_recall": "Lack of Assurance of Sterility: There are also CGMP Deviations.", "recall_initiation_date": "20170210", "center_classification_date": "20170315", "termination_date": "20170523", "report_date": "20170322", "code_info": "All Lots"}, {"status": "Terminated", "city": "Tarrytown", "state": "NY", "country": "United States", "classification": "Class III", "openfda": {}, "product_type": "Drugs", "event_id": "68130", "recalling_firm": "Prestige Brands Holdings", "address_1": "660 White Plains Rd", "address_2": "", "postal_code": "10591-5139", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide, and one consignee in Libya", "recall_number": "D-1353-2014", "product_description": "PediaCare brand DAY & NIGHT Value Pack DAYTIME MULTI-SYMPTOM Cold (dextromethorphan HBr 5 mg and Phenylephrine HCl 2.5 mg) and NIGHTTIME MULTI-SYMPTOM Cold (diphenhydramine HCl 6.25 mg and phenylephrine HCl 2.5 mg), 4 FL oz (118 mL) bottles, one each of DAYTIME MULTI-SYMPTOM Cold, Distributed by Medtech Products, Inc., Tarrytown, NY --- UPC 814832013523", "product_quantity": "17,479 cases/12 dual packs", "reason_for_recall": "Presence of Precipitate; small amounts of diphenhydramine precipitated out of solution", "recall_initiation_date": "20140425", "center_classification_date": "20140528", "termination_date": "20150915", "report_date": "20140604", "code_info": "UPC 814832013523    Lots: Expiry Date  148342 07/2015  148347 08/2015  149297 08/2015  149382 07/2015  149516 08/2015  152298 08/2015  73143 04/2014  73719 05/2014  74195 06/2014  74805 06/2014  75180 06/2014  79186 09/2014  79323 09/2014", "more_code_info": ""}, {"status": "Terminated", "city": "Daytona Beach", "state": "FL", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "80750", "recalling_firm": "Product Quest Manufacturing LLC", "address_1": "330 Carswell Ave", "address_2": "N/A", "postal_code": "32117-4416", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA", "recall_number": "D-0063-2019", "product_description": "Walgreens, NO DRIP, Anefrin Nasal Spray (Oxymetazoline HCl 0.05%), Nasal Decongestant, Original, 12 Hour, Maximum Strength, 0.5 FL OZ (15 mL) bottle, Distributed By: Walgreen Co., 200 Wilmot Rd., Deerfield, IL 60015,NDC 0363-7005-01, UPC 3 11917 18537 8.", "product_quantity": "355,056 bottles", "reason_for_recall": "CGMP Deviations: products manufactured under conditions that could impact its product quality.", "recall_initiation_date": "20180803", "center_classification_date": "20181016", "termination_date": "20210330", "report_date": "20181024", "code_info": "All lots remaining within expiry."}, {"status": "Terminated", "city": "Colonia", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "83427", "recalling_firm": "Colonia Care Pharmacy", "address_1": "515 Inman Ave Ste A", "address_2": "N/A", "postal_code": "07067-1114", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Patient Specific Prescriptions in NJ", "recall_number": "D-0019-2020", "product_description": "C-PAPAV/PHENTOL/PGE1 10MG/1MG/10MCG/ML, packaged in a) 5 mL and b) 10 mL vials, Rx only, Colonia Care Pharmacy, 515 Inman Ave., Suite A, Colonia, N.J. 07067", "product_quantity": "6 vials", "reason_for_recall": "Lack of Assurance of Sterility: product sterility cannot be guaranteed.", "recall_initiation_date": "20190724", "center_classification_date": "20191001", "termination_date": "20230405", "report_date": "20191009", "code_info": "Lot #: a) and b) 071119E, BUD 08/25/19"}, {"status": "Terminated", "city": "Toronto", "state": "", "country": "Canada", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "70452", "recalling_firm": "Attix Pharmaceuticals", "address_1": "184 Front St E", "address_2": "unit 801", "postal_code": "N/A", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit", "distribution_pattern": "Nationwide to compounding pharmacies and research organizations.", "recall_number": "D-648-2015", "product_description": "Enalapril Maleate active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada", "product_quantity": "100 grams", "reason_for_recall": "Penicillin Cross Contamination: All lots of all products repackaged and distributed between 01/05/12 and 02/12/15 are being recalled because they were repackaged in a facility with penicillin products without adequate separation which could introduce the potential for cross contamination with penicillin.", "recall_initiation_date": "20141114", "center_classification_date": "20150420", "termination_date": "20151007", "report_date": "20150429", "code_info": "All lots repackaged and distributed between 01/05/12 to 02/12/15", "more_code_info": ""}, {"status": "Terminated", "city": "Ocala", "state": "FL", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "75289", "recalling_firm": "Wells Pharmacy Network LLC", "address_1": "1210 SW 33rd Ave", "address_2": "N/A", "postal_code": "34474-2853", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "Nationwide", "recall_number": "D-0408-2017", "product_description": "Tri 2 (PAP/PHEN/ATROPINE) NR Injectable, 30 mg/3 mg/0.3 mg/mL, a) 2 mL and b) 5 mL vials, Compounded by Wells Pharmacy, Ocala, FL", "product_quantity": "a) 238 vials and b) 607 vials", "reason_for_recall": "Lack of Assurance of Sterility", "recall_initiation_date": "20160921", "center_classification_date": "20170104", "termination_date": "20210702", "report_date": "20170111", "code_info": "All lot codes of product prepared between 02/22/2016 and 09/14/2016, within expiry.     a) Known lot code: 05042016@19, 06142016@28, 07262016@34, 09072016@22    b) Known lot code: 04112016@8, 05232016@2, 06212016@21, 07012016@22, 09082016@31."}, {"status": "Terminated", "city": "Houston", "state": "TX", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "81002", "recalling_firm": "Pharm D Solutions, LLC", "address_1": "1304 S Loop W", "address_2": "N/A", "postal_code": "77054-4010", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "Nationwide", "recall_number": "D-0199-2019", "product_description": "Trimix Papaverine/Phentolamine/Alprostadil 30 mg/1 mg/10 mcg Powder Pharm D Solutions, Houston, Texas --- NDC 69699-1365-10", "product_quantity": "715 vials", "reason_for_recall": "Lack of Assurance of Sterility", "recall_initiation_date": "20180910", "center_classification_date": "20181101", "termination_date": "20210205", "report_date": "20181107", "code_info": "Lot: 03292018:02 Discard by: 9/24/2018; 05302018:54 Discard by: 11/26/2018; 06062018:79 Discard by: 12/3/2018; 06122018:31 Discard by: 11/17/2018; 07252018:44 Discard by: 1/21/2019"}, {"country": "United States", "city": "Vancouver", "address_1": "14301 Se 1st St", "reason_for_recall": "Labeling: Label Mixup: MYCOPHENOLATE MOFETIL, Capsule, 250 mg may have potentially been mislabeled as the following drug:  PRAMIPEXOLE DI-HCL, Tablet, 0.25 mg, NDC 16714058501, Pedigree: W003761, EXP: 6/26/2014.", "address_2": "", "product_quantity": "100 Capsules", "code_info": "MYCOPHENOLATE MOFETIL, Capsule, 250 mg has the following codes:   Pedigree: W003763, EXP: 6/26/2014.", "center_classification_date": "20140120", "distribution_pattern": "Repacked drugs were distributed in Arizona, California, Oregon, and Washington.", "state": "WA", "product_description": "MYCOPHENOLATE MOFETIL, Capsule, 250 mg, Rx only, Distributed by: AidaPak Service, LLC, NDC 00378225001.", "report_date": "20140129", "classification": "Class II", "openfda": {}, "recalling_firm": "Aidapak Services, LLC", "recall_number": "D-904-2014", "initial_firm_notification": "Telephone", "product_type": "Drugs", "event_id": "65690", "termination_date": "20140207", "more_code_info": "", "recall_initiation_date": "20130702", "postal_code": "98684-3501", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Terminated", "city": "Lenoir", "state": "NC", "country": "United States", "classification": "Class I", "openfda": {"application_number": ["ANDA211091"], "brand_name": ["SODIUM BICARBONATE"], "generic_name": ["SODIUM BICARBONATE"], "manufacturer_name": ["Exela Pharma Sciences, LLC"], "product_ndc": ["51754-5001", "51754-5011", "51754-5002", "51754-5012"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["INTRAVENOUS"], "substance_name": ["SODIUM BICARBONATE"], "rxcui": ["807284", "1868486", "1923484", "2198792"], "spl_id": ["4da0ba66-756d-4b4d-8018-81ca16578ef1"], "spl_set_id": ["e9698a4f-1a95-4f28-a945-e8009d1d6dd4"], "package_ndc": ["51754-5001-5", "51754-5001-4", "51754-5011-4", "51754-5002-5", "51754-5012-4", "51754-5001-1"], "is_original_packager": [true], "unii": ["8MDF5V39QO"]}, "product_type": "Drugs", "event_id": "90956", "recalling_firm": "Exela Pharma Sciences LLC", "address_1": "1245 Blowing Rock Blvd", "address_2": "N/A", "postal_code": "28645-3618", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide within the United States", "recall_number": "D-0022-2023", "product_description": "8.4% Sodium Bicarbonate Injection, USP 50 mEq/50 mL (1 mEq/mL) 50 mL Single Dose Vials, packaged in cartons of 20 vials, Rx only, Manufactured and Distributed by: Exela Pharma Sciences, LLC Lenoir, NC 28645. Carton NDC 51754-5001-5, vial NDC 51754-5001-1", "product_quantity": "2,123,040 vials", "reason_for_recall": "Defective Container: Complaints received of vial breakage and glass flying when pressurized while preparing the product for administration", "recall_initiation_date": "20221004", "center_classification_date": "20221027", "termination_date": "20251010", "report_date": "20221102", "code_info": "Lot # : P0001370, P0001371, P0001372, Exp. 10/2023; P0001433, P0001434 Exp. 11/2023; P0001443, P0001468, P0001469, P0001470, P0001495, P0001505, P0001506, P0001509, P0001510, P0001511, P0001512 Exp. 12/2023; P0001560, P0001561, P0001562, P0001564, P0001566, P0001567, P0001568 Exp. 01/2024; P0001571, P0001572, P0001573, P0001574, P0001578, P0001579, P0001580, P0001583, P0001586, P0001587, P0001588, P0001593, P0001594, P0001610, P0001618, P0001619, P0001654 Exp. 02/2024; P0001644, P0001645, P0001646, P0001662, P0001664 Exp. 03/2024; P0001730 Exp. 05/2024.", "more_code_info": ""}, {"status": "Terminated", "city": "Tulsa", "state": "OK", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "71618", "recalling_firm": "The Apothecary Shoppe LLC", "address_1": "6136 E 51st St", "address_2": "N/A", "postal_code": "74135-7704", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Oklahoma", "recall_number": "D-1313-2015", "product_description": "SIU-Prostaglandin E1 500 mcg/mL Injection, Rx Only, 10 mL Vial, Apothecary Shoppe, Compounding Pharmacy, Tulsa OK 74135", "product_quantity": "N/A", "reason_for_recall": "Lack of Assurance of Sterility: Due to lack of documentation of proper environmental monitoring during the time in which the medication was produced.", "recall_initiation_date": "20150626", "center_classification_date": "20150806", "termination_date": "20170217", "report_date": "20150812", "code_info": "Lot #: 05042015@33, BUD 10/31/2015; 03102015@45, 03112015@14, 03192015@42, BUD 09/01/2015"}, {"status": "Terminated", "city": "Sharm", "state": "N/A", "country": "United Arab Emirates", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "73420", "recalling_firm": "Sun Pharma Global Fze", "address_1": "Office # 43 Block Y Saif Zone", "address_2": "N/A", "postal_code": "N/A", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "E-Mail", "distribution_pattern": "Nationwide and Puerto Rico", "recall_number": "D-0735-2016", "product_description": "Alendronate Sodium Tablets, USP, 70 mg*, 4-count blisters per carton, Rx only, Manufactured by: Sun Pharmaceutical Ind. Ltd., Halol-Baroda Highway, Halol-389 350, Gujarat, India; Distributed by: Sun Pharmaceutical Industries, Inc., Cranbury, NJ  08512; NDC 41616-638-68, UPC 3 41616 63868 4.", "product_quantity": "381,120 cartons", "reason_for_recall": "Failed Impurities/Degradation Specifications: Observed levels of highest unknown impurity exceeding specification limit at the 3 month stability time point.", "recall_initiation_date": "20160211", "center_classification_date": "20160303", "termination_date": "20170523", "report_date": "20160309", "code_info": "Lot #s: JKP2234A, JKP2235A, Exp 04/17"}, {"status": "Terminated", "city": "Asheville", "state": "NC", "country": "United States", "classification": "Class I", "openfda": {}, "product_type": "Drugs", "event_id": "80601", "recalling_firm": "King Bio Inc.", "address_1": "3 Westside Dr", "address_2": "N/A", "postal_code": "28806-2846", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "U.S.A. Nationwide, Canada, and Australia.", "recall_number": "D-0642-2019", "product_description": "Dr. King's Natural Medicine Homeopathic Jet Lag & Shift Change, 2 fl. oz. (59 mL), King Bio, Inc., 3 Westside Dr. Asheville, NC 28806, UPC 357955512622, NDC 57955-5126-2", "product_quantity": "377 bottles", "reason_for_recall": "Microbial contamination", "recall_initiation_date": "20180720", "center_classification_date": "20190308", "termination_date": "20220119", "report_date": "20190320", "code_info": "Lots: 060216D Exp. 06/19"}, {"status": "Terminated", "city": "Plainsboro", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "82196", "recalling_firm": "Macleods Pharma Usa Inc", "address_1": "666 Plainsboro Rd Bldg 200 Ste 230", "address_2": "N/A", "postal_code": "08536-0009", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide within the United States", "recall_number": "D-1004-2019", "product_description": "Telmisartan and Hyrdochlorothiazide Tablets, USP 80mg/12.5 mg, 30-coun bottles, Rx Only, Manufactured for: Macleods Pharma USA, Inc. Plainsboro, NJ  08536 Manufactured by: Macleods Pharmaceuticals Ltd. Baddi, Imachal Pradesh, India NDC 33342-129-07", "product_quantity": "140,589 bottles", "reason_for_recall": "Failed Content Uniformity Specifications: The product is out of specification for blend uniformity.", "recall_initiation_date": "20190225", "center_classification_date": "20190314", "termination_date": "20210712", "report_date": "20190320", "code_info": "Lot #: BTM703A, BTM704A, BTM706A, BTM707A, Exp Feb-19; TM708A,BTM709A, Exp Apr-19; BTM710A, Exp Jun-19; BTM711A, BTM712A, Exp Oct-19; BTM713A,BTM714A,  BTM715A, Exp Nov-19;   BTM801A, BTM802A, BTM803A, BTM804A, Exp Dec-19; BTM806A,BTM807A, Exp Mar-20; BTM809A Exp Apr-20; BTM810A, BTM811A, BTM812A, Exp. Jul-20; BTM813A, BTM814A, BTM815A, BTM816A, BTM817A, Exp Sep-20; BTM818A, BTM819A Exp Nov-20."}, {"country": "United States", "city": "Springerville", "address_1": "105 W Main St", "reason_for_recall": "Lack of Assurance of Sterility", "address_2": "", "product_quantity": "15 containers", "code_info": "all lots", "center_classification_date": "20151201", "distribution_pattern": "Nationwide in US: Arizona, California, Georgia, New Mexico, South Carolina, South Dakota, Texas, and Utah", "state": "AZ", "product_description": "Super B Comp w/Cyano 3X Inj, Rx, Western Drug Inc. 106 E. Main Street, Springerville, Arizona 85938", "report_date": "20151209", "classification": "Class II", "openfda": {}, "recalling_firm": "Western Drug", "recall_number": "D-0454-2016", "initial_firm_notification": "Telephone", "product_type": "Drugs", "event_id": "72520", "termination_date": "20161001", "more_code_info": "", "recall_initiation_date": "20151019", "postal_code": "85938-7203", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Terminated", "city": "Mesa", "state": "AZ", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "83669", "recalling_firm": "First Royal Care Co. LLC, dba Red Mountain Compounding Pharmacy", "address_1": "6828 E Brown Rd Ste 101", "address_2": "N/A", "postal_code": "85207-3761", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA", "recall_number": "D-0262-2020", "product_description": "S-ESTRADIOL CYP 5MG/ML MDV INJ IN SESAME OIL, packaged in a) 5ml, b) 10ml, c) 11ml, glass vials, Rx Only, Red Mountain Compounding RX.", "product_quantity": "1x5ml, 7x10ml, 3x11ml, glass vials", "reason_for_recall": "Lack of Assurance of Sterility", "recall_initiation_date": "20190812", "center_classification_date": "20191105", "termination_date": "20230413", "report_date": "20191113", "code_info": "Lot #:S05092019DH@07, Exp 8/9/19;  S05082019DT@11, Exp 8/8/19;  S07032019DT@13, Exp 10/3/19; S07092019DT@09, Exp 10/9/19; S07292019DH@03, Exp 10/29/19"}, {"status": "Ongoing", "city": "Thane", "state": "", "country": "India", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "93885", "recalling_firm": "Brassica Pharma Pvt Ltd", "address_1": "Plot No. T-68, T 68 (Pt), T-63, Midc", "address_2": "Tarapur, Boisar", "postal_code": "N/A", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide within the United States", "recall_number": "D-0353-2024", "product_description": "CVS Health Lubricant Eye Ointment (Mineral oil 31.9%  Emollient, White petrolatum 57.7% Emollient), Packaged in in 3.5 gram tubes, Distributed by: CVS Pharmacy, Inc. One CVS Drive Woonsocket, RI 02895, NDC 76168-707-35, UPC 050428634141", "product_quantity": "159,334 units", "reason_for_recall": "Lack of Assurance of Sterility", "recall_initiation_date": "20240130", "center_classification_date": "20240228", "report_date": "20240306", "code_info": "Lot #:  A2F03, Exp. Date May-24;  A2I02, Exp. Date Aug-24; A2L02, Exp. Date Nov-24; A3C04, Exp. Date Feb-25; A3H04, Exp. Date Jul-25", "more_code_info": ""}, {"status": "Ongoing", "city": "Princeton", "state": "NJ", "country": "United States", "classification": "Class III", "openfda": {"application_number": ["ANDA077091"], "brand_name": ["GLIMEPIRIDE"], "generic_name": ["GLIMEPIRIDE"], "manufacturer_name": ["Dr. Reddy's Laboratories Limited"], "product_ndc": ["55111-320", "55111-321", "55111-322"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["GLIMEPIRIDE"], "rxcui": ["199245", "199246", "199247"], "spl_id": ["e3d50334-9896-b2f9-a481-8383eb84b16a"], "spl_set_id": ["07ad4366-4b21-f633-49f3-c2b35f88168d"], "package_ndc": ["55111-320-30", "55111-320-01", "55111-320-05", "55111-320-79", "55111-320-78", "55111-321-30", "55111-321-01", "55111-321-05", "55111-321-79", "55111-321-78", "55111-322-30", "55111-322-01", "55111-322-05", "55111-322-79", "55111-322-78"], "is_original_packager": [true], "nui": ["N0000175608", "M0020795"], "pharm_class_epc": ["Sulfonylurea [EPC]"], "pharm_class_cs": ["Sulfonylurea Compounds [CS]"], "unii": ["6KY687524K"]}, "product_type": "Drugs", "event_id": "93833", "recalling_firm": "Dr. Reddy's Laboratories, Inc.", "address_1": "107 College Rd E", "address_2": "", "postal_code": "08540-6623", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide", "recall_number": "D-0312-2024", "product_description": "Glimepiride Tablets, USP 1mg, 100-count bottles, Rx Only, Mfd. By: Dr. Reddy's Laboratories Limited, Srikakulam-532 409 INDIA, NDC: 55111-320-01", "product_quantity": "59,336 bottles", "reason_for_recall": "Misprint on tablet", "recall_initiation_date": "20240118", "center_classification_date": "20240206", "report_date": "20240214", "code_info": "Lot: T2303622; Exp. 06/2026 Lot: T2303626; Exp. 06/2026 Lot: T2303627; Exp. 06/2026 Lot: T2303628; Exp. 06/2026 Lot: T2303629; Exp. 06/2026", "more_code_info": ""}, {"status": "Terminated", "city": "Dawsonville", "state": "GA", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA091629"], "brand_name": ["LOSARTAN POTASSIUM AND HYDROCHLOROTHIAZIDE"], "generic_name": ["LOSARTAN POTASSIUM AND HYDROCHLOROTHIAZIDE"], "manufacturer_name": ["Direct_Rx"], "product_ndc": ["72189-012", "72189-098", "72189-129", "72189-139", "72189-167"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["HYDROCHLOROTHIAZIDE", "LOSARTAN POTASSIUM"], "rxcui": ["979464", "979468", "979471"], "spl_id": ["2becfaea-c7d6-ec34-e063-6294a90af5b3"], "spl_set_id": ["8de04bf2-83dd-c494-e053-2a95a90abade"], "package_ndc": ["72189-012-90", "72189-098-90", "72189-129-90", "72189-129-30", "72189-139-30", "72189-139-90", "72189-167-30", "72189-167-90"], "original_packager_product_ndc": ["65862-468", "0093-7369", "59746-337", "59746-339", "68180-216"], "nui": ["N0000175359", "N0000175419", "M0471776"], "pharm_class_pe": ["Increased Diuresis [PE]"], "pharm_class_epc": ["Thiazide Diuretic [EPC]"], "pharm_class_cs": ["Thiazides [CS]"], "unii": ["0J48LPH2TH", "3ST302B24A"]}, "product_type": "Drugs", "event_id": "90161", "recalling_firm": "Direct Rx", "address_1": "94 Worldwide Dr", "address_2": "N/A", "postal_code": "30534-6828", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "AL, GA, FL, LA", "recall_number": "D-0971-2022", "product_description": "Losartan Pot./HCTZ 100/12.5 mg Packaged and Distributed By: Direct Rx Dawsonville, GA 30534 Mfg For: Lupin Pharmaceuticals, Inc. Baltimore, MD 21202 a) 30 Tabs NDC 72189-167-30; b) 90 Tabs NDC 72189-167-90", "product_quantity": "81 bottles", "reason_for_recall": "CGMP Deviations- AZIDO Impurity levels observed to be above acceptable limits", "recall_initiation_date": "20220505", "center_classification_date": "20220527", "termination_date": "20231005", "report_date": "20220608", "code_info": "a) 30-count bottles-    Lot: 11MY2103 Exp. 11/30/22  Lot: 05JA2106 Exp. 6/30/22      b) 90-count bottles-       Lot: 20MY2115 Exp. 11/30/22  Lot: 22JU2118 Exp. 12/31/22  Lot: 29JY2113 Exp. 12/31/22  Lot: 13SE2113 Exp. 2/28/23  Lot: 05JA2106 Exp. 6/30/22"}, {"status": "Terminated", "city": "Tampa", "state": "FL", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "83996", "recalling_firm": "Coast Quality Pharmacy, LLC dba Anazao Health", "address_1": "5710 Hoover Blvd", "address_2": "N/A", "postal_code": "33634-5339", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Telephone", "distribution_pattern": "Nationwide in the U.S.", "recall_number": "D-0600-2020", "product_description": "Morphine Sulfate and Bupivacaine HCL and Clonidine HCL in all strengths, all doses and all packaging AnazaoHealth 5710 Hoover Blvd Tampa, FL 33634 (800) 995-4363", "product_quantity": "Unknown", "reason_for_recall": "Lack of Processing Controls; Environmental sampling revealed 1 CFU (Colony Forming Unit) identified as Talaromyces rotundus, a fungi.", "recall_initiation_date": "20190903", "center_classification_date": "20191206", "termination_date": "20201201", "report_date": "20191218", "code_info": "All lots filled and dispensed on 08/26-29/2019 and 09/27/2019 through 10/03/2019 remaining within expiry.", "more_code_info": ""}, {"country": "United States", "city": "Asheville", "address_1": "752 Biltmore Ave", "reason_for_recall": "Lack of Sterility Assurance: All lots of sterile products compounded by the pharmacy that are not expired due to concerns associated with quality control procedures that present a potential risk to sterility assurance that were observed during a recent FDA inspection.", "address_2": "", "product_quantity": "", "code_info": "All lot numbers within expiry.", "center_classification_date": "20140304", "distribution_pattern": "NC", "state": "NC", "product_description": "Cyano B-12 (Cmpd) 1000mcg/ml", "report_date": "20140312", "classification": "Class II", "openfda": {}, "recalling_firm": "Natures Pharmacy & Compounding Center", "recall_number": "D-1105-2014", "initial_firm_notification": "Telephone", "product_type": "Drugs", "event_id": "66856", "termination_date": "20140424", "more_code_info": "", "recall_initiation_date": "20131101", "postal_code": "28803-2558", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"country": "United States", "city": "Ocala", "address_1": "1210 SW 33rd Avenue", "reason_for_recall": "Lack of Assurance of Sterility: Franck's Lab Inc. initiated a recall of all Sterile Human Drugs distributed between 11/21/2011 and 05/21/2012. FDA environmental sampling revealed the presence of microorganisms and fungal growth in the clean room where sterile products were prepared.", "address_2": "", "product_quantity": "14 units", "code_info": "Rx #'s:  0407225    0407852      0405175    0408193    0403243    0404737    0392573    0392575    0392577    0392575    0401951      0404831", "center_classification_date": "20120810", "distribution_pattern": "Nationwide, Bahamas, Columbia, Dominican Republic, Grand Cayman, Guatemala, Poland, Santo Domingo, Venezuela, West Indies", "state": "FL", "product_description": "KETOROLAC TROMETHAMINE 30MG/ML INJECTABLE\t10 ML  \t  \t  \t24 ML  \t  \t500 ML;  KETOROLAC TROMETHAMINE 60MG/ML INJECTABLE\t48 ML;  KETOROLAC TROMETHAMINE, 1ML SDV**25X1ML 30MG/ML INJECTABLE\t50 ML  \t  \t  \t75 ML;  KETOROLAC TROMETHAMINE, P.F. 60MG/ML INJECTABLE\t10 ML  (7 DIFFERENT PRODUCTS)", "report_date": "20120822", "classification": "Class II", "openfda": {}, "recalling_firm": "Franck's Lab Inc., d.b.a. Franck's Compounding Lab", "recall_number": "D-1552-2012", "initial_firm_notification": "Letter", "product_type": "Drugs", "event_id": "62443", "termination_date": "20140815", "more_code_info": "", "recall_initiation_date": "20120521", "postal_code": "34474-5138", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"country": "United States", "city": "Vancouver", "address_1": "14301 Se 1st St", "reason_for_recall": "Labeling: Label Mixup; prednisoLONE, Tablet, 5 mg may be potentially mislabeled as    ASPIRIN/ER DIPYRIDAMOLE, Capsule, 25 mg/200 mg, NDC 00597000160, Pedigree: W003644, EXP: 8/24/2013.", "address_2": "", "product_quantity": "100 Tablets", "code_info": "prednisoLONE, Tablet, 5 mg has the following code    Pedigree: W003627, EXP: 6/25/2014.", "center_classification_date": "20140116", "distribution_pattern": "Repacked drugs were distributed in Arizona, California, Oregon, and Washington.", "state": "WA", "product_description": "prednisoLONE, Tablet, 5 mg, Rx only, Distributed by: AidaPak Service, LLC,NDC 16477050501", "report_date": "20140122", "classification": "Class II", "openfda": {}, "recalling_firm": "Aidapak Services, LLC", "recall_number": "D-513-2014", "initial_firm_notification": "Telephone", "product_type": "Drugs", "event_id": "65707", "termination_date": "20140207", "more_code_info": "", "recall_initiation_date": "20130702", "postal_code": "98684-3501", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Terminated", "city": "Horsham", "state": "PA", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA040361"], "brand_name": ["DEXTROAMPHETAMINE SULFATE"], "generic_name": ["DEXTROAMPHETAMINE SULFATE"], "manufacturer_name": ["Teva Pharmaceuticals USA, Inc."], "product_ndc": ["0555-0952", "0555-0953"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["DEXTROAMPHETAMINE SULFATE"], "rxcui": ["884385", "884386"], "spl_id": ["e339af0f-084a-4d19-8013-3ccb826816d0"], "spl_set_id": ["ec2d13f3-d14f-47e4-abe9-7763f95a8e94"], "package_ndc": ["0555-0952-02", "0555-0953-02"], "is_original_packager": [true], "unii": ["JJ768O327N"]}, "product_type": "Drugs", "event_id": "68225", "recalling_firm": "Teva Pharmaceuticals USA", "address_1": "425 Privet Rd", "address_2": "N/A", "postal_code": "19044-1220", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide and Puerto Rico", "recall_number": "D-1408-2014", "product_description": "Dextroamphetamine Sulfate Tablets, USP, 10 mg, 100-count bottles, Rx only, Barr Laboratories, Inc., Pomona, NY 10970, NDC 0555-0953-02.", "product_quantity": "9,882 bottles", "reason_for_recall": "Failed Impurities/Degradation Specifications: this product is being recalled due to an out of specification test result for impurities during stability testing.", "recall_initiation_date": "20140501", "center_classification_date": "20140623", "termination_date": "20141209", "report_date": "20140702", "code_info": "Lot # 34013122A, Exp 11/15"}, {"status": "Terminated", "city": "Vicksburg", "state": "MS", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "79748", "recalling_firm": "Kroger Specialty Pharmacy, Inc.", "address_1": "100 Pear Orchard Dr Ste A", "address_2": "N/A", "postal_code": "39180-7153", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "MS, LA, AR, IL, FL", "recall_number": "D-0784-2018", "product_description": "Sprycel 100 mg tablet NDC 00003-0852-22 30 days supply", "product_quantity": "Unknown", "reason_for_recall": "Lack of Processing Controls.", "recall_initiation_date": "20180403", "center_classification_date": "20180510", "termination_date": "20200507", "report_date": "20180516", "code_info": "All lots remaining within expiry dispensed 12/01/2017 through 02/12/2018"}, {"status": "Terminated", "city": "Deerfield", "state": "IL", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA075591"], "brand_name": ["FAMOTIDINE"], "generic_name": ["FAMOTIDINE"], "manufacturer_name": ["Baxter Healthcare Corporation"], "product_ndc": ["0338-5197"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["INTRAVENOUS"], "substance_name": ["FAMOTIDINE"], "rxcui": ["199739"], "spl_id": ["19d9e59f-3373-4237-b252-d3d6ba9e58cd"], "spl_set_id": ["97c33213-f415-4718-8466-9aa50371af70"], "package_ndc": ["0338-5197-41"], "is_original_packager": [true], "nui": ["N0000000151", "N0000175784"], "pharm_class_moa": ["Histamine H2 Receptor Antagonists [MoA]"], "pharm_class_epc": ["Histamine-2 Receptor Antagonist [EPC]"], "unii": ["5QZO15J2Z8"]}, "product_type": "Drugs", "event_id": "68171", "recalling_firm": "Baxter Healthcare Corp.", "address_1": "1 Baxter Pkwy", "address_2": "N/A", "postal_code": "60015-4625", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide", "recall_number": "D-0293-2015", "product_description": "Famotidine Injection 20 mg, Rx Only, GALAXY Single Dose Container, Code 2G3424, Sterile Nonpyrogenic, 50 mL Iso-osmotic,  Baxter Healthcare Corporation, Deerfield, IL 60015, USA, NDC 0338-5197-41.", "product_quantity": "19,152 Containers", "reason_for_recall": "Presence of Particulate Matter: Baxter Healthcare Corporation has received a complaint reporting the presence of particulate matter identified as plastic/rubber in famotidine Injection premixed containers.", "recall_initiation_date": "20140424", "center_classification_date": "20141210", "termination_date": "20150616", "report_date": "20141217", "code_info": "Lot #: NC082768, Exp 12/23/2014"}, {"status": "Terminated", "city": "Yuyao", "state": "N/A", "country": "China", "classification": "Class III", "openfda": {}, "product_type": "Drugs", "event_id": "83018", "recalling_firm": "NingBo Huize Commodity Co.,Ltd.", "address_1": "14 Lizhou Road", "address_2": "N/A", "postal_code": "N/A", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Telephone", "distribution_pattern": "Foreign manufacturer located in China and distributed to seven consignees located in China.", "recall_number": "D-1538-2019", "product_description": "DOTS SCENTED ANTIBACTERIAL HAND GEL ORANGE (Ethyl Alcohol 62%), 1.35 fl oz / 40 mL, OTC, Distributed by: JFL Enterprises, Inc. Cleveland, Ohio 44102.", "product_quantity": "3852", "reason_for_recall": "CGMP deviations: Stability testing was not conducted on manufactured sunscreen and hand sanitizer OTC products.", "recall_initiation_date": "20190401", "center_classification_date": "20190727", "termination_date": "20230606", "report_date": "20190807", "code_info": "Lot #: 20181019, Exp 10/18/2020"}, {"status": "Terminated", "city": "San Antonio", "state": "TX", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "72594", "recalling_firm": "Walgreens Infusion Services", "address_1": "14220 Northbrook Dr Ste 100B", "address_2": "N/A", "postal_code": "78232-5045", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Texas", "recall_number": "D-0539-2016", "product_description": "Ceftriaxone 2g/NS 100 mL Minibag Plus, Rx Only, Compounded by Option Care 148, San Antonio, TX 78232-5045", "product_quantity": "46 Minibags", "reason_for_recall": "Lack of Assurance of Sterility", "recall_initiation_date": "20151110", "center_classification_date": "20151230", "termination_date": "20171018", "report_date": "20160106", "code_info": "All lots within expiry."}, {"status": "Terminated", "city": "Yonkers", "state": "NY", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "92453", "recalling_firm": "Homeocare Laboratories, Inc.", "address_1": "7 Odell Plz Ste 142-146", "address_2": "N/A", "postal_code": "10701-1407", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Product was distributed USA nationwide.", "recall_number": "D-0888-2023", "product_description": "StellaLife VEGA Oral Care Spray, 1 fl oz (30 ml) bottles, Distributed by: StellaLife, Inc., Aventura, FL NDC 69685-101-02", "product_quantity": "40,034/1 fl. oz tubes", "reason_for_recall": "cGMP deviations", "recall_initiation_date": "20230605", "center_classification_date": "20230626", "termination_date": "20240916", "report_date": "20230705", "code_info": "Lot # 2335, exp. date Sep-23; 2364, exp. date Nov-23; 2408, exp. date Feb-24", "more_code_info": ""}, {"status": "Ongoing", "city": "Nicholasville", "state": "KY", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "89909", "recalling_firm": "TMC Acquisition LLC dba Tailor Made Compounding", "address_1": "200 Moore Dr", "address_2": "", "postal_code": "40356-8512", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide USA and Puerto Rico", "recall_number": "D-1227-2022", "product_description": "Sermorelin/Glycine 2000mcg/5mg/mL, 4mL-vial, Refrigerate, Tailor Made Compounding", "product_quantity": "1,562 vials", "reason_for_recall": "Lack of Assurance of Sterility", "recall_initiation_date": "20220307", "center_classification_date": "20220714", "report_date": "20220720", "code_info": "Batch#: 11102107A2, Exp 4/9/202211232104A1, Exp 5/7/2022; 02212229A1, 11292103A2, Exp 5/22/2022; 12132105A2, Exp 5/24/2022; 02282207A1, Exp 5/29/2022; 03082209A1, Exp 6/6/2022; 03112231B, Exp 6/9/2022; 01042212A1, Exp 6/27/2022.", "more_code_info": ""}, {"country": "United States", "city": "Little Rock", "address_1": "1527 S Bowman Rd Ste D", "reason_for_recall": "Lack of Assurance of Sterility: Sterility of product is not assured.", "address_2": "", "product_quantity": "1 Bag", "code_info": "Compounded on 05/29/15, Discard After: 06/26/15", "center_classification_date": "20150701", "distribution_pattern": "United States including: Arkansas", "state": "AR", "product_description": "Fentanyl Citrate, FENTANYL 25,000 MCG / 500 ML, Qty: 1 500 mL Bag, Rx Only.  Compounded by: United Medical IV Center (Little Rock) 1527 South Bowman Rd. Ste. D Little Rock, AR 72211-4200.", "report_date": "20150708", "classification": "Class II", "openfda": {}, "recalling_firm": "Lincare, Inc.", "recall_number": "D-1187-2015", "initial_firm_notification": "Telephone", "product_type": "Drugs", "event_id": "71415", "termination_date": "20170216", "more_code_info": "", "recall_initiation_date": "20150528", "postal_code": "72211-4200", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Terminated", "city": "Phoenix", "state": "AZ", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "80000", "recalling_firm": "Vitalab Pharmacy, Inc", "address_1": "4045 E Bell Rd Ste 163", "address_2": "N/A", "postal_code": "85032-2240", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "The recalled product was distributed to patients throughout the United States.", "recall_number": "D-0733-2018", "product_description": "Papaverine 30mg/Phentolamine 2mg/Prostaglandin 20mcg/mL,  Papaverine 30mg/Phentolamine 1mg/Prostaglandin 10mcg/mL,  Papaverine 30mg/Phentolamine 1mg/Prostaglandin 25mcg/mL, sterile injectables, Vitalab Pharmacy, Inc", "product_quantity": "60 vials", "reason_for_recall": "Lack of assurance of sterility: Upon review of recent 3rd party environmental certification documentation, it was determined that airflow patterns may not be sufficient to support the aseptic production of certain injectable drug products.", "recall_initiation_date": "20180424", "center_classification_date": "20180509", "termination_date": "20200123", "report_date": "20180516", "code_info": "Lot #:T101 03062018@69, 02052018@56, T104 03122018@62, 02072018@95, T105 03122018@63, 02072018@96, T106 03122018@64, 02072018@97, Exp 06/04/2018-06/10/2018"}, {"status": "Terminated", "city": "Colchester", "state": "VT", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "89172", "recalling_firm": "Edge Pharma, LLC", "address_1": "856 Hercules Dr", "address_2": "", "postal_code": "05446-8014", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "nationwide", "recall_number": "D-0421-2022", "product_description": "Phenylephrine HCl/Tropicamide/Cyclopentolate HCl/Ketorolac Sterile Ophthalmic Solution, 2.5%/0.25%/0.25%/0.125%, 0.5 mL syringe, Single Use Syringe, For Topical Ophthalmic Use,  NDC 05446-0993-01", "product_quantity": "2562 syringes", "reason_for_recall": "Lack of Assurance of Sterility", "recall_initiation_date": "20211206", "center_classification_date": "20220124", "termination_date": "20230607", "report_date": "20220202", "code_info": "09-2021-15@2 12/28/2021 & 11-2021-02@3 02/14/2022", "more_code_info": ""}, {"status": "Terminated", "city": "Spokane", "state": "WA", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "83253", "recalling_firm": "First Pharma Associates LLC dba Riverpoint Pharmacy", "address_1": "1802 N Monroe St", "address_2": "", "postal_code": "99205-4528", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Telephone", "distribution_pattern": "ID, WA only", "recall_number": "D-1468-2019", "product_description": "Testosterone Cypionate 100 mg/mL Sesame Oil Injection, 12mL vial,  Rx only, First Pharma Associates dba Riverpoint Pharmacy, Spokane, WA 99205, (509) 343-6252", "product_quantity": "24 mL", "reason_for_recall": "Lack of Assurance of Sterility.", "recall_initiation_date": "20190626", "center_classification_date": "20190711", "termination_date": "20230606", "report_date": "20190717", "code_info": "Lot #: 04192019@1, Exp. 07/21/2019;  05312019@4, Exp. 09/03/2019", "more_code_info": ""}, {"status": "Terminated", "city": "Roseburg", "state": "OR", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "81883", "recalling_firm": "Hiers Enterprises, LLC dba Northwest Compounding Pharmacy", "address_1": "1350 Ne Stephens St Ste 42", "address_2": "N/A", "postal_code": "97470-6410", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Product was distributed exclusively in the state of Oregon to 3 Medical facilities, 1 Physician's office and 80 consumers/patients.    These are compounded products - labels vary for each compound - specific to each patient.  Firm did not provide labeling.", "recall_number": "D-0394-2019", "product_description": "Glutathione liquid, 100mg/ml", "product_quantity": "60 ml", "reason_for_recall": "Lack of sterility assurance.", "recall_initiation_date": "20190102", "center_classification_date": "20190127", "termination_date": "20230328", "report_date": "20190109", "code_info": "10292018@17"}, {"country": "United States", "city": "Henderson", "address_1": "1850 Whitney Mesa Dr", "reason_for_recall": "Lack of Assurance of Sterility: all sterile products compounded, repackaged, and distributed by this compounding pharmacy due to lack of sterility assurance and concerns associated with the quality control processes.", "address_2": "Suite 180", "product_quantity": "43 vials", "code_info": "Lot #: a) Nandrolone Decanoate 300 mg/mL: 20130311-J, Exp 6/11/2013", "center_classification_date": "20130516", "distribution_pattern": "Nationwide", "state": "NV", "product_description": "Nandrolone Decanoate Injection, all strengths and all presentations including a) Nandrolone Decanoate 300 mg/mL, b) Nandrolone 200 mg/mL, c) Nandrolone 250 mg/mL, d) Nandrolone 350 mg/mL, Rx only, Green Valley Drugs, 1850 Whitney Mesa, #180, Henderson, NV  89014.", "report_date": "20130522", "classification": "Class II", "openfda": {}, "recalling_firm": "FVS Holdings, Inc. dba. Green Valley Drugs", "recall_number": "D-397-2013", "initial_firm_notification": "Press Release", "product_type": "Drugs", "event_id": "64879", "termination_date": "20140321", "more_code_info": "", "recall_initiation_date": "20130410", "postal_code": "89014-2091", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Ongoing", "city": "Amman", "state": "", "country": "Jordan", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "92974", "recalling_firm": "AMMAN PHARMACEUTICAL INDUSTRIES", "address_1": "Building 108", "address_2": "Street A3, King Abdullah Ii Industrial City", "postal_code": "N/A", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Product was distributed to two (2) direct accounts in RI and CO.", "recall_number": "D-1155-2023", "product_description": "TRP Natural Eyes, Dryness Relief, Sterile Eye Drops, Homeopathic 0.33 FL OZ (10 mL), Manufactured in Jordan, exclusively for TRP Company, Inc., 1575 Delucchi Lane, Reno, NV 89502, NDC:17312-178-15.", "product_quantity": "196,111 units", "reason_for_recall": "Lack of Assurance of Sterility", "recall_initiation_date": "20230901", "center_classification_date": "20230915", "report_date": "20230927", "code_info": "Lot: IX001 EXP: 07/24; Lot: IX002 EXP: 12/24", "more_code_info": ""}, {"status": "Terminated", "city": "Los Angeles", "state": "CA", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "84978", "recalling_firm": "Fusion IV Pharmaceuticals, Inc. dba Axia Pharmaceutical", "address_1": "1990 Westwood Blvd Ste 135", "address_2": "N/A", "postal_code": "90025-4650", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "U.S.A. Nationwide and Puerto Rico, Barbados and Dominican Republic", "recall_number": "D-0980-2020", "product_description": "Pyridoxine Hydrochloride Injection, PYRIDOXINE HCL 100 MG/ML INJECTABLE, For IV, IM Use, 30 mL Multi-dose Vial, Rx only, Axia Pharmaceutical 1990 Westwood Blvd. Ste 135, Los Angeles, CA 90025; NDC 71283-0216-3", "product_quantity": "N/A", "reason_for_recall": "Lack of Assurance of Sterility", "recall_initiation_date": "20200115", "center_classification_date": "20200305", "termination_date": "20231207", "report_date": "20200311", "code_info": "Lot #: 09132019+52914, Exp 2/28/2020; 09162019+52920, Exp 3/2/2020; 09192019+52939; Exp 2/28/2020; 10292019+53162, Exp 4/14/2020; 12112019+53369, Exp 5/27/2020"}, {"status": "Terminated", "city": "Sugar Land", "state": "TX", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "85773", "recalling_firm": "QuVa Pharma, Inc.", "address_1": "1075 W Park One Dr Ste 100", "address_2": "N/A", "postal_code": "77478-2576", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "USA Nationwide", "recall_number": "D-1302-2020", "product_description": "oxyTOCIN 30 Units/500 mL (0.06 Units/mL) added to 0.9% Sodium Chloride Injection for IV Use, Rx only, QuVa Pharma 1075 West Park One Drive, Suite 100 Sugar Land, TX 77478 888-339-0874, NDC 70092-1068-07", "product_quantity": "648 bags", "reason_for_recall": "Subpotent drug - Product did not contain drug.", "recall_initiation_date": "20200528", "center_classification_date": "20200611", "termination_date": "20220119", "report_date": "20200617", "code_info": "Lot#:  30010515"}]